On this page
Quick Reference
Overview and Recommendations
Background
- •Acute otitis media (AOM) is an acute infection of the middle ear cleft, the tympanic cavity, eustachian tube, and mastoid air cells, that presents with rapid-onset middle ear effusion and signs of inflammation. It must be distinguished from otitis media with effusion (OME), which lacks acute inflammation, and from recurrent AOM (≥4 episodes per year) and chronic suppurative otitis media (CSOM, >6 weeks of discharge).
- •AOM is predominantly a disease of early childhood: peak incidence occurs between 6 and 24 months, with a median of one episode per year in the second year of life. It accounts for approximately 15 million healthcare visits annually in the United States and is the most common indication for antibiotic therapy in children, though about 55-60% of untreated cases resolve spontaneously within 24-48 hours.
- •The pathophysiologic cascade begins with viral upper respiratory infection (most often RSV) causing eustachian tube dysfunction, which creates negative middle ear pressure and draws nasopharyngeal secretions, containing Streptococcus pneumoniae, nontypeable Haemophilus influenzae, and Moraxella catarrhalis, into the sterile middle ear. Toll-like receptors and NOD-like receptors recognize bacterial components, triggering release of TNF-α, IL-1β, IL-6, and IL-8, which drive mucosal edema, neutrophil recruitment, and hyperplasia.
- •Untreated or severe AOM can progress to complications in about 0.26% of emergency department visits: acute mastoiditis (0.16%), labyrinthitis (0.06%), and facial nerve paresis (0.03%). Intracranial extension (meningitis, sigmoid sinus thrombosis, brain abscess) is rare but carries significant morbidity. Extended high-frequency hearing loss (8-16 kHz) may persist even after standard audiometry normalizes, particularly when inflammation lasts >10 days.
- •Key variants and severity grades inform management: bilateral AOM in children <2 years and AOM with otorrhea identify subgroups with the largest absolute antibiotic benefit (NNT 3-4). The Japanese severity classification (mild/moderate/severe) integrates age, fever, otalgia, and tympanic membrane bulging to guide initial therapy. Recurrent AOM (≥3 episodes in 6 months or ≥4 in 12 months) may warrant tympanostomy tube placement in children with documented middle ear effusion at the time of assessment.
Evaluation
- •Suspect AOM in any child (especially aged 6-24 months) or adult with acute-onset ear pain (older children verbalize earache; infants present with crying, ear tugging, disturbed sleep), fever (present in ~50%, temperature ≥39°C increases likelihood), and hearing difficulty that may manifest as inattention. A preceding upper respiratory infection is common.
- •Ask about otalgia severity, fever height, laterality, duration of symptoms (<48 hours suggests AOM vs OME), prior episodes (to identify recurrent AOM), daycare attendance, smoke exposure, breastfeeding history, and penicillin allergy.
- •Examine the tympanic membrane (TM) using pneumatic otoscopy, the gold standard bedside tool. The three diagnostic criteria are: (1) bulging of the TM (most specific sign; positive likelihood ratio >20), (2) opacity with loss of normal landmarks, and (3) limited mobility on pneumatic insufflation. Erythema alone is insufficient (can result from crying or fever). Otorrhea (purulent drainage from a TM perforation) confirms diagnosis but occurs in only 5-10% of cases.
- •Classify severity: mild disease (unilateral, mild otalgia, temperature <39°C, age >2 years, no otorrhea) vs severe disease (bilateral, severe otalgia, temperature ≥39°C, age <2 years, or otorrhea present). The Japanese guidelines further stratify into mild, moderate, and severe based on age, fever, and otoscopic findings.
- •Order no routine imaging for uncomplicated AOM. Contrast-enhanced CT of temporal bone is indicated if complications are suspected: persistent fever >39°C, postauricular swelling/erythema (mastoiditis), facial nerve palsy, vertigo/nystagmus (labyrinthitis), or meningeal signs (intracranial extension). MRI with gadolinium better defines intracranial complications and serous labyrinthitis (3D FLAIR enhancement).
- •Consider tympanometry and optical coherence tomography (OCT) as adjuncts in equivocal cases. Tympanometry classifies middle ear status (type A normal, type B effusion, type C negative pressure). OCT has 74% sensitivity and 93% specificity for middle ear effusion and changed diagnosis/treatment in 15.3% of children in one trial.
- •In children with tympanostomy tubes presenting with otorrhea, diagnose acute tympanostomy tube otorrhea (AOMT). Examine for granulation tissue and debris. Topical antibiotic-corticosteroid drops are first-line; systemic antibiotics are not indicated for uncomplicated AOMT.
- •Assess for risk factors for recurrence or complications: age <2 years, bilateral AOM, craniofacial anomalies (e.g., cleft palate), immunocompromise (including cochlear implants), chronic medical conditions (adjusted IRR 2.1 for ≥2 comorbidities), and 22q11.2 deletion syndrome (42.2% develop recurrent AOM).
- •In adults, obtain a baseline audiogram if sensorineural hearing loss is suspected (tinnitus, vertigo, high-frequency loss). SNHL complicates AOM in 9.3% of adult cases, most commonly at high frequencies; recovery averages 18.6 days with treatment. Extended high-frequency audiometry (8-16 kHz) may detect residual cochlear damage not visible on standard testing.
- •Also consider: OME (effusion without acute inflammation), CSOM (chronic perforation with discharge >6 weeks), and foreign body or otitis externa in children with otorrhea. Red flags requiring urgent ENT consultation: postauricular swelling/erythema/auricle protrusion (mastoiditis), facial nerve palsy, vertigo/nystagmus, and meningeal signs.
Management
- •Initiate analgesia immediately for all children with AOM: administer paracetamol (acetaminophen) 15 mg/kg PO/PR every 4-6 hours as needed, or ibuprofen 10 mg/kg PO every 6-8 hours. Paracetamol may reduce pain at 48 hours (NNT 7). Topical anaesthetic drops lack sufficient evidence for routine use.
- •For mild, unilateral AOM in children >2 years without otorrhea, offer watchful waiting with a safety-net antibiotic prescription. Spontaneous resolution occurs in ~60% within 24 hours and ~80% by 2-3 days. Antibiotics reduce pain at 2-3 days (NNT 20) but increase adverse events (NNT harm 14). Shared decision-making is essential.
- •For children <2 years with bilateral AOM or any child with severe disease (age <2 years, bilateral, severe otalgia, fever ≥39°C, or otorrhea), prescribe antibiotics immediately. First-line: amoxicillin-clavulanate 90 mg/kg/day of the amoxicillin component PO divided twice daily for 10 days. This reduces clinical failure from ~23% to 4% at day 4-5 (NNT 5) in children 6-23 months.
- •For penicillin-allergic patients (non-IgE mediated), use cefdinir 14 mg/kg/day PO once or divided twice daily for 10 days. For severe penicillin allergy (IgE-mediated), consider ceftriaxone 50 mg/kg IM/IV once daily for 3 days, then transition to oral therapy if defervescence occurs.
- •Monitor for treatment response at 48-72 hours: if symptoms worsen or fail to improve, re-examine to confirm diagnosis and check for complications. For persistent severe disease, switch to ceftriaxone 50 mg/kg IM/IV daily for 3 days. Consider myringotomy (± tympanostomy tube) for toxic children with severe otalgia or persistent otorrhea despite topical therapy.
- •For acute tympanostomy tube otorrhea (AOMT), treat with topical ciprofloxacin 0.3% plus fluocinolone 0.025% otic solution twice daily for 7 days, this is superior to ciprofloxacin alone (median time to cessation 4.23 vs 6.95 days; clinical cure 80.6% vs 67.4%). Oral antibiotics are not indicated for uncomplicated AOMT.
- •Do NOT prescribe antihistamines or decongestants for AOM or OME, no benefit and increased side effects (NNH 9). Do NOT use oral or nasal corticosteroids for OME. Do NOT use antireflux therapy for AOM. Do NOT treat OME with antibiotics.
- •Refer for tympanostomy tube evaluation in children with recurrent AOM (≥3 episodes in 6 months or ≥4 in 12 months) AND documented middle ear effusion at the time of assessment. Tubes do not significantly reduce the AOM rate over 2 years (1.48 vs 1.56 episodes per child-year, P=0.66) but improve secondary outcomes and quality of life.
- •In children ≥4 years undergoing initial tympanostomy tube placement, consider concurrent adenoidectomy: it reduces the odds of repeat tube insertion (OR 0.46). For children without MEE at evaluation, 91% do not require tubes within one year; provide semiurgent return precautions for new AOM episodes.
- •Admit for IV antibiotics and ENT consultation if: toxic appearance, age <6 months with severe disease, suspected suppurative complication (mastoiditis, facial palsy, labyrinthitis, intracranial extension), or inability to tolerate oral antibiotics. For acute mastoiditis with subperiosteal abscess, conservative management (IV antibiotics + myringotomy + needle aspiration) succeeds in 94% of cases; cortical mastoidectomy is reserved for failures.
- •After resolution of the acute episode, assess for persistent middle ear effusion and manage per OME guidelines. If sensorineural hearing loss is suspected, refer for audiometry. For children with recurrent AOM despite tubes, evaluate for biofilm on the tube and consider tube removal/cleaning or topical therapy targeted to culture results.
Board Review — High Yield
- •Pneumatic otoscopy, The three diagnostic criteria: bulging (LR+ >20), opacity with loss of landmarks, and limited mobility. Erythema alone is insufficient.
- •Spontaneous resolution, 60% recover within 24 hours without antibiotics; watchful waiting is appropriate for mild, unilateral AOM in children >2 years.
- •Antibiotic benefit subgroups, Bilateral AOM in children <2 years and AOM with otorrhea have NNT of 3-4; otherwise healthy children >2 years with unilateral mild AOM have NNT ~20.
- •Amoxicillin-clavulanate 90 mg/kg/day, First-line for 10 days in children <2 years with severe disease; 5-day courses are inferior (34% vs 16% clinical failure).
- •Topical ciprofloxacin-fluocinolone, First-line for acute tympanostomy tube otorrhea; faster cessation (4.23 vs 6.95 days) and higher cure (80.6% vs 67.4%) than antibiotic alone.
- •Tympanostomy tubes, Do not reduce AOM rate over 2 years (1.48 vs 1.56 episodes/child-year, P=0.66) but improve secondary outcomes. Reserved for recurrent AOM with documented MEE.
- •Acute mastoiditis, Most common complication (0.16% ED visits); treat with IV antibiotics and myringotomy ± needle aspiration; 94% resolve without mastoidectomy.
- •Vaccination prevention, PCV13 reduced AOM hospitalizations by 34%; influenza vaccine modestly reduces AOM (RR 0.80, NNT 25).
- •Extended high-frequency hearing loss, May persist after standard audiometry normalizes, especially if inflammation >10 days; consider EHF audiometry (8-16 kHz) in patients with tinnitus.
- •Do NOT use antihistamines/decongestants, corticosteroids, or antireflux therapy for AOM or OME, no benefit and increased harm.
Deep Dive — Evidence Details
Definition, Classification and Anatomic Localization
- ▸AOM is defined by acute onset, middle ear effusion, and inflammation; OME lacks acute inflammation.
- ▸Recurrent AOM is defined as ≥4 episodes per year [13]; AOM with discharge (AOMd) specifies perforation with otorrhea ≤6 weeks.
- ▸Severity classification (mild/moderate/severe) based on age, symptoms, and otoscopic findings guides initial management in Japanese guidelines [8].
Acute otitis media (AOM) is an acute infection of the middle ear characterized by rapid onset of middle ear effusion and signs of inflammation. The condition is anatomically confined to the middle ear cleft, which includes the tympanic cavity, eustachian tube, and mastoid air cells; the tympanic membrane (TM) provides the primary clinical window for diagnosis.
Also Called / Synonyms
- Acute suppurative otitis media
- Acute middle ear infection
- "Ear infection" (colloquial)
- Abbreviation: AOM
Classification and Key Definitions
AOM must be distinguished from related middle ear disorders that differ in natural history and .
| Term | Abbreviation | Key Feature | Duration / Recurrence |
|---|---|---|---|
| Acute otitis media | AOM | Acute infection with middle ear effusion and inflammation | Onset <48 hours; resolves within weeks |
| Otitis media with effusion | OME | Middle ear effusion without acute inflammation | Can persist for months after AOM |
| Recurrent acute otitis media | RAOM | Repeated AOM episodes | ≥4 episodes per year [13]A1c |
| AOM with discharge | AOMd | AOM with tympanic membrane perforation and purulent otorrhea | Duration ≤6 weeks [13]A1c |
| Chronic suppurative otitis media | CSOM | Persistent TM perforation with chronic discharge | >6 weeks |
Recurrent AOM (RAOM) is defined by expert consensus as ≥4 episodes per year [13]A1c; in clinical practice, ≥3 episodes in 6 months is also used [2]A1c. AOM with discharge (AOMd) specifically denotes an acute perforation with otorrhea of up to 6 weeks, a subset that is often more unwell and may require different treatment than AOM without perforation [13]A1c. In vaccine trials, clinical AOM (C-AOM) is diagnosed by physician assessment with otoscopy, while bacterial AOM (B-AOM) requires positive middle ear fluid culture [15]A1b.
Severity grading further stratifies management. The Japanese 2018 guidelines classify AOM as mild, moderate, or severe based on three factors: age (<3 vs ≥3 years), clinical manifestations (fever intensity, otalgia), and otoscopic findings (degree of TM bulging, erythema) [8]D5. This classification directly informs initial antibiotic decisions in that guideline.
Clinical Significance
AOM is the leading cause of healthcare visits and antibiotic prescriptions for children in the United States [4]B2b. It accounts for substantial morbidity, with approximately 15% of cases progressing to TM perforation [13]A1c. Children with chronic medical conditions have significantly higher incidence rates; those with two or more comorbidities have an adjusted incidence rate ratio of 2.1 for AOM/sinusitis compared with healthy peers [16]B2b.
The pathophysiologic cascade that produces these distinct clinical phenotypes, from to the host inflammatory response, is detailed in the next section.
Pearl: Severity classification (mild/moderate/severe) based on age, symptoms, and otoscopic findings guides initial management in Japanese guidelines [8]D5.
Pathophysiology and Mechanism
- ▸Impaired Eustachian tube function from viral infection leads to bacterial invasion of the middle ear; RSV co-infection with bacteria is common.
- ▸TLRs and NLRs are central to pathogen recognition; dysregulated NLR expression predisposes to chronicity and recurrence.
- ▸Inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8) drive mucosal remodeling, protease-mediated tissue damage, and, via round window penetration, serous labyrinthitis and enhanced aminoglycoside ototoxicity.
From the sterile middle ear cleft, the pathogenetic chain begins when upper respiratory infection, usually viral, impairs function, creating negative pressure that draws nasopharyngeal secretions, and their microbial flora, into the middle ear space [24]A1a[42]D5. This initial event launches a sequenced inflammatory-structural derangement that, if unchecked, progresses from mucosal edema to ossicular remodeling and, rarely, intracranial extension.
and Microbial Access
Respiratory viruses disrupt mucociliary clearance and induce tubal edema, converting the Eustachian tube from a protective conduit into a portal for bacterial entry [24]A1a[38]D5. is detected in up to 23% of AOM-associated samples and co-infection with bacteria occurs in approximately 70% of RSV-positive middle ear fluids [24]A1a. , nontypeable , and are the dominant bacterial isolates; non-culturable organisms like are also recovered in a substantial minority of effusions [34]B2b.
Innate Immune Response
Bacterial components are recognized by host pattern-recognition receptors expressed on middle ear epithelium and resident macrophages. Toll-like receptors (TLRs 1-10) and NOD-like receptors (NLRs) are upregulated upon infection [40]D5[41]D5. In experimental AOM, TLR expression shifts from absent or weak in healthy mucosa to robust in inflammatory fluid [41]D5. NLR signaling, particularly via NOD2, influences disease severity and chronicity; impaired NLR expression predisposes to recurrence [40]D5. Macrophages infiltrate the cochlear lateral wall within hours of middle ear inoculation [27]D5.
Inflammatory Cascade and Mucosal Remodeling
Activation of TLRs and NLRs triggers release of pro-inflammatory cytokines, TNF-α, IL-1β, IL-6, and IL-8, which are present at high concentrations in middle ear effusions [30]B3b. These cytokines increase vascular permeability, recruit neutrophils, and stimulate mucosal hyperplasia. Proteases released by host cells and bacteria degrade extracellular matrix; a single dose of the protease inhibitor alpha1-antitrypsin showed a trend toward faster resolution in an animal model, supporting the role of protease activity in tissue damage [23]D5. Persistent inflammation promotes goblet cell metaplasia and subepithelial fibrosis, setting the stage for chronic otitis media with effusion.
Bone and Inner Ear Consequences
The inflammatory milieu directly affects ossicular bone. In a rat pneumococcal AOM model, initial osteoresorption of the ossicles was followed by progressive new bone apposition over 28 days; ossicular changes were delayed and less extensive than remodeling of the surrounding cavity wall, suggesting that ossicular tissue is relatively resistant to modeling [33]D5. may potentiate this process: in rats, calcium supplementation increased the prevalence of tympanosclerosis from 16.7% to 25% (relative risk 1.27) [35]D5.
Inflammatory mediators can penetrate the round window, increasing perilymph protein content and disrupting the blood-labyrinth barrier, a mechanism that underlies serous labyrinthitis and presents clinically as direction-changing positional nystagmus [28]C4. Concurrently, cochlear inflammation, macrophage infiltration and cytokine upregulation, enhances uptake of ototoxic aminoglycosides into the stria vascularis and hair cells, justifying the clinical caution against gentamicin use during AOM [27]D5. Spread of infection to the mastoid air cells may lead to and, in rare instances, to thrombus formation in adjacent dural sinuses via cytokine-driven activation of the coagulation cascade [37]D5.
Controversies and Guideline Disagreement
| Question | Position A | Position B | Strength | Implication |
|---|---|---|---|---|
| Is Alloiococcus otitidis a true AOM pathogen? | Yes, it is the most frequent isolate in OME (48.3%) and may trigger inflammation [34]B2b | No, causality is unproven; it may be a commensal [36]D5 | Low | Current antibiotic therapy does not target A. otitidis; if pathogenic, treatment failure may result [34]B2b |
Pearl: A single episode of AOM initiates a biphasic bone response, early resorption followed by new bone formation, which, with recurrent episodes, can permanently alter ossicular compliance [33]D5; prevention of recurrences is therefore essential for preserving long-term middle ear mechanics.
| Receptor Family | Members Expressed | Expression Changes in AOM | Functional Consequence |
|---|---|---|---|
| Toll-like receptors (TLRs) | TLR1-10 | Upregulated in middle ear fluid; absent/weak in healthy mucosa [41]D5 | Triggers cytokine release and neutrophil recruitment |
| NOD-like receptors (NLRs) | NOD2, NLRP3 | Increased with bacterial presence; impaired expression linked to recurrence [40]D5 | Influences disease severity, chronicity, and complications |
Clinical Presentation
- ▸Pain is the cardinal symptom; analgesics (paracetamol or NSAIDs) should be first-line, with an NNT of 7 for pain relief at 48 hours.
- ▸Bulging of the tympanic membrane is the most specific otoscopic sign for AOM, with positive likelihood ratio >20.
- ▸Complications occur in only 0.26% of pediatric ED visits; red flags include postauricular swelling, facial palsy, vertigo, and meningeal signs.
From these risk factors and epidemiologic patterns emerges a clinical syndrome that, while often stereotypical, pivots on the otoscopic examination. The classic presentation is a child, typically between 6 and 24 months, with acute-onset ear pain, fever, and irritability, often preceded by an upper respiratory tract infection [1]A1b[47]A1b. However, the clinical features vary by age, severity, and the presence of complications.
Presenting Symptoms
Pain is the cardinal symptom. Older children verbalize earache; infants and toddlers present with crying, tugging at the ear, disturbed sleep, and feeding difficulty [55]A1a[58]A1a. Fever is present in roughly half of cases, and when temperature exceeds 39°C, the likelihood of AOM increases [1]A1b[90]B2c. Hearing loss is common but often overlooked acutely; the child may appear inattentive or unresponsive. Accompanying symptoms include rhinorrhea, cough, and vomiting [67]B2b. Among children aged 0-2 years, the peak symptomatic period is the second year of life, with a median of one episode per year [52]C4.
Otoscopic Findings
The diagnosis of AOM rests on three otoscopic criteria: 1) bulging of the tympanic membrane (TM), 2) opacity with loss of normal landmarks, and 3) limited mobility on pneumatic otoscopy [4]B2b[73]C4. Bulging is the most specific sign for AOM, with a positive likelihood ratio >20. Erythema alone is insufficient, as it can occur from crying or fever. Otorrhea, purulent drainage through a TM perforation, confirms the diagnosis but occurs in only 5-10% of cases [90]B2c. The presence of middle ear effusion (MEE) must be distinguished from ; in AOM the onset is acute (<48 hours) and accompanied by inflammation [53]C4[73]C4. Optical coherence tomography (OCT) is an emerging adjunct that improves diagnostic accuracy, particularly for MEE detection, with sensitivity 90.9% and specificity 90.2% in one study [53]C4[92]B2b.
Severity and Red Flags
Most AOM episodes are self-limited, but certain features predict a more aggressive course or imminent complication.
Mild disease: Low-grade fever (<39°C), mild otalgia, unilateral involvement. Observation with is an option.
Moderate-severe disease: High fever (≥39°C), severe otalgia, bilateral involvement, or age <6 months [47]A1b[63]A1a. Antibiotic therapy is warranted.
Red flags requiring urgent evaluation:
- Postauricular swelling, erythema, or auricle protrusion → suspect acute with subperiosteal abscess [88]B2b.
- Facial nerve paresis → rare (0.03% of ED visits) but ominous; usually recovers without decompression [77]C4[90]B2c.
- Vertigo, nystagmus, or sensorineural hearing loss → suggest labyrinthitis or petrous apicitis [48]C4[84]C4[90]B2c.
- Meningeal signs, altered consciousness, or headache → suspect intracranial extension (meningitis, intracranial abscess) [68]C4[90]B2c.
Complications overall occur in 0.26% of pediatric AOM emergency department visits; the most common are (0.16%), labyrinthitis (0.06%), and facial paresis (0.03%) [90]B2c. Among adults, sensorineural hearing loss complicates 9.3% of AOM cases, preferentially affecting high frequencies [84]C4. Extended high-frequency (EHF) hearing loss (8-16 kHz) may persist even after standard audiometry normalizes, and is associated with residual [72]B2b[86]C4.
Atypical Presentations
- Toddlers with chronic suppurative otitis media may present with painless otorrhea and hearing loss; recurrent AOM in childhood increases the risk of dizziness and tinnitus in adulthood (OR 2.1 and 1.6, respectively) [49]B2b[65]B2b.
- Infants with craniofacial anomalies (e.g., cleft palate) have a higher incidence of recurrent AOM and need for multiple tympanostomy tube placements [52]C4.
- Post-COVID era has seen a shift: children with RSV-related AOM are older and present with higher inflammatory markers and more severe disease [67]B2b.
- Gradenigo’s triad (abducens palsy, otorrhea, retro-orbital pain) is present in only 20.9% of petrous apicitis cases; individual symptoms are more common (abducens palsy 51.5%, retro-orbital pain 64.2%) [48]C4.
Pearl: The combination of acute-onset ear pain and a bulging, opaque tympanic membrane on otoscopy has the highest positive predictive value for AOM (likelihood ratio >20), this single finding should drive the decision to treat, not erythema or fever alone.
Controversies and Guideline Disagreement
| Question | Position A | Position B | Strength | Implication |
|---|---|---|---|---|
| Should severe bilateral AOM in children <2 years always be treated with ? | AAO-HNS / AAP: 90 mg/kg/day for 10 days [47]A1b | Watchful waiting may be considered if parents are reliable [55]A1a | Moderate | Shared decision-making; treatment reduces pain at 2-3 days (NNT 20) [55]A1a[62]A1a |
| Is pneumatic otoscopy mandatory for diagnosis? | AAO-HNS: Yes, to assess mobility [44]C4 | Many clinicians rely on otoscopy alone; OCT may improve accuracy [53]C4[92]B2b | High | Training deficit in pneumatic otoscopy remains [44]C4 |
The next section, Audiologic, Vestibular and Endoscopic Assessment, details the specialized testing that confirms the presence and nature of middle ear effusion and quantifies any hearing loss.
| Feature | Frequency | Clinical Significance |
|---|---|---|
| Ear pain (otalgia) | >80% | Cardinal symptom; guides need for analgesia |
| Fever ≥39°C | ~50% | Marker of moderate-severe disease; associated with bilateral AOM [47]A1b |
| Bulging tympanic membrane | 60-80% | Most specific diagnostic sign; LR+ >20 |
| Otorrhea | 5-10% | Confirms TM perforation; may indicate more severe infection |
| Hearing loss (conductive) | Transient | Usually resolves; persistent loss suggests OME or SNHL |
| Irritability / crying | Common in infants | Nonspecific; correlates with pain |
| Sign | Suspected Complication | Action |
|---|---|---|
| Postauricular swelling, erythema, ear protrusion | Acute mastoiditis / subperiosteal abscess | Urgent ENT referral; CT temporal bone |
| Facial nerve paresis | Facial neuritis | Start antibiotics; myringotomy; no routine decompression [77]C4 |
| Vertigo, nystagmus, high-frequency hearing loss | Labyrinthitis / petrous apicitis | Audiogram; CT/MRI; consider IV antibiotics |
| Meningeal signs (nuchal rigidity, photophobia) | Meningitis | Lumbar puncture; empiric antibiotics; imaging |
| Headache, vomiting, altered consciousness | Intracranial abscess / venous sinus thrombosis | Immediate neurosurgical consultation; CT/MRI |
Audiologic, Vestibular and Endoscopic Assessment
- ▸Extended high-frequency audiometry (8-16 kHz) reveals subclinical sensorineural hearing loss after AOM that persists despite normalization of standard thresholds, and its recovery time correlates with the duration of inflammation.
- ▸Tubomanometry (TMM) is an independent predictor of medical therapy response in adult acute otitis media with effusion: a TMM value ≥1.5 confers a 66.7% response rate versus 20.7% for lower values.
- ▸Childhood recurrent AOM and chronic suppurative otitis media double the risk of adult dizziness (OR 2.1), underscoring the need for vestibular history in follow-up.
The transition from clinical presentation to objective assessment begins with the functional battery, a graded, serially tracked set of tests that quantifies middle ear and inner ear involvement in Acute Otitis Media. Unlike imaging, which captures anatomy, these tools capture physiology and its trajectory over time.
Audiologic Assessment
Standard pure-tone audiometry remains the cornerstone. In children aged 9 to 11 years with a history of recurrent AOM, the prevalence of sensorineural hearing loss (≥16 dB HL at low- or high-frequency pure-tone averages) is 7.8%, with an odds ratio of 2.0 (95% CI 1.5‑2.8) for recurrent AOM as an independent risk factor [64]C4. After a first episode of unilateral AOM, standard thresholds (250 Hz‑8 kHz) typically normalize once the air‑bone gap closes, but extended high-frequency (EHF) audiometry (8‑16 kHz) reveals a persistent threshold elevation that does not recover within 6 months [72]B2b. The recovery time of EHF thresholds is closely correlated with the duration of inflammation: patients whose symptoms resolve within ≤5 days show earlier EHF recovery than those with inflammation lasting >10 days [86]C4. In adults, SNHL complicates AOM in 9.3% of ears, most commonly affecting high frequencies, with a mean bone‑conduction threshold of 39.5 dB and a mean recovery time of 18.6 days with , myringotomy, and steroids [84]C4.
Speech audiometry correlates strongly with pure‑tone average (R² up to 0.77 at 65 dB SPL) across middle‑ear pathologies, but disease‑specific effects exist: for a given PTA, patients with AOM or chronic otitis media show better word recognition than those with [98]B2b. Tympanometry is essential for classifying middle‑ear status, type A (normal), type B (effusion), type C (negative pressure), and is used as an outcome measure in trials: antibiotics reduce abnormal tympanometry at 2‑4 weeks (RR 0.82; NNT 11) but not at 3 months [62]A1a[63]A1a. In cleft‑palate children, rapid maxillary expansion improves both air‑bone gaps and tympanometric patterns, an effect that persists at 6‑month follow‑up [83]B2b. Acoustic stapedial reflex thresholds are elevated after mastoidectomy, while distortion‑product otoacoustic emissions (DPOAE) and middle‑ear impedance otherwise show no long‑term change [32]C4. Auditory brainstem response has been used in animal models but is seldom needed in routine clinical AOM assessment [23]D5.
Vestibular Assessment
Childhood chronic suppurative otitis media and hearing loss after recurrent AOM are associated with a two‑fold increased risk of dizziness in adulthood (OR 2.1, 95% CI 1.4‑3.3), suggesting permanent vestibular effects of inflammatory mediators [49]B2b. In the acute setting, AOM complicated by serous labyrinthitis produces persistent geotropic direction‑changing positional nystagmus (DCPN) on the ‑roll test; this arises from increased perilymph density due to inflammatory exudate and blood‑labyrinth barrier breakdown, generating a buoyant force on the cupula. The nystagmus pattern can evolve over hours to days and is confirmed by 3D‑FLAIR MRI enhancement in the inner ear [28]C4. Formal videonystagmography is indicated when vertigo is present, though most uncomplicated AOM cases do not require vestibular testing.
Endoscopic and Eustachian Tube Assessment
Pneumatic otoscopy is the first‑line bedside tool; its accuracy is augmented by digital otoscopy with blinded central review of images for purulent otorrhea, hyperemia, and granulation, a method used in pivotal trials of topical antibiotics (e.g., 1.5% otic solution, 46.5% improvement rate vs 23.5% placebo) [95]A1b. Optical coherence tomography (OCT) is an emerging, noninvasive technique that identifies middle‑ear effusion with a sensitivity of 74% and specificity of 93%, comparable to pneumatic otoscopy and tympanometry, with moderate inter‑rater agreement (κ = 0.41) [73]C4.
Tubomanometry (TMM) measures Eustachian tube opening pressure. In adult acute OME, a TMM value ≥1.5 (on a 0‑6 scale) predicts medication response with 72.7% sensitivity and 74.2% specificity (AUC 0.773); ears with TMM 2‑6 have a 66.7% response rate versus 20.7% for TMM 0‑1 [100]B2b. TMM is also used to monitor outcomes after balloon Eustachian tuboplasty (BET) in children with chronic tube dysfunction, where improvements in tympanometry and hearing threshold (median from 20 dB HL to 10 dB HL) parallel TMM normalization [99]C4[101]C4.
Pearl: Extended high-frequency audiometry (8‑16 kHz) detects persistent cochlear damage that standard audiometry misses; a normal standard audiogram after AOM does not rule out hidden hearing loss, especially in patients who report or when inflammation lasted >10 days [72]B2b[86]C4.
| Modality | What It Measures | Key Finding in AOM | Clinical Use |
|---|---|---|---|
| Standard pure‑tone audiometry | Air and bone conduction thresholds (250‑8000 Hz) | Conductive loss acutely; SNHL in 9.3% of adults [84]C4 | Baseline and follow‑up; detect persistent HL |
| Extended high‑frequency audiometry | Thresholds 8‑16 kHz | Persistent elevation after first OM episode [72]B2b | Detect hidden cochlear damage; monitor recovery over months |
| Speech audiometry | Word recognition at 65 dB SPL | R² up to 0.77 with PTA; better performance in AOM vs otosclerosis [98]B2b | Assess functional hearing disability |
| Tympanometry | Middle‑ear admittance vs pressure | Type B (effusion) or C (negative pressure) | Diagnose MEE; monitor resolution (NNT 11 at 2‑4 weeks) [62]A1a |
| Acoustic stapedial reflex | Reflex threshold | Elevated after mastoidectomy [32]C4 | Part of impedance battery in complicated cases |
| DPOAE | Outer hair cell function | Absent with cochlear involvement | Screen for cochlear damage |
| Videonystagmography | Spontaneous and positional nystagmus | Geotropic DCPN in serous labyrinthitis [28]C4 | Confirm vestibular involvement when vertigo present |
| Optical coherence tomography (OCT) | Middle‑ear effusion visualization | Sensitivity 74%, specificity 93% [73]C4 | Emerging noninvasive alternative to pneumatic otoscopy |
| Tubomanometry (TMM) | Eustachian tube opening pressure | TMM ≥1.5 predicts medication response (72.7% sens, 74.2% spec) [100]B2b | Guide need for medical vs surgical therapy |
| Digital otoscopy with BICRC | Endoscopic images of TM and middle ear | Purulent otorrhea, hyperemia, granulation [95]A1b | Standardized outcome assessment in clinical trials |
Diagnostic Imaging, Tissue Sampling and Workup
- ▸Imaging (contrast-enhanced CT) is reserved for suspected complications of AOM; uncomplicated cases require no imaging.
- ▸Incidental mastoid opacification on MRI/CT is common and rarely requires treatment, clinical correlation is essential to avoid unnecessary care.
- ▸Optical coherence tomography (OCT) and AI classifiers are emerging adjuncts that improve diagnostic accuracy for middle ear effusion in equivocal cases.
With the functional and endoscopic assessment complete, the diagnostic workup escalates when clinical suspicion for complicated acute otitis media (AOM) arises. Imaging is not indicated for uncomplicated AOM; its role is to evaluate suspected suppurative complications, , petrous apicitis, Luc abscess, sigmoid sinus thrombosis, or intracranial extension [48]C4[112]B3b[117]C4.
Imaging Modalities and Indications
Contrast-enhanced computed tomography (CT) of the temporal bone is the first-line study for suspected complicated AOM. CT demonstrates mastoid air cell opacification, bony erosion, subperiosteal abscess, and sigmoid sinus thrombosis [79]C4[112]B3b[113]B2c. In children with high fever, leukocytosis (mean 20 K/μL), elevated CRP (mean 17 mg/dL), and subperiosteal abscess, early CT and surgical intervention are frequently required [112]B3b. Magnetic resonance imaging (MRI) with gadolinium better defines intracranial complications (cerebral venous sinus thrombosis, epidural abscess) and can detect serous labyrinthitis via 3D FLAIR enhancement of the inner ear [28]C4[117]C4. However, caution: incidental mastoid opacification on MRI or CT performed for nonotologic indications is common, 82% of patients with radiological "mastoiditis" on MRI had no clinical otologic disease [70]C4[111]C4. Clinical correlation is mandatory; unnecessary or otolaryngology consultations should be avoided [70]C4.
Optical coherence tomography (OCT) is an emerging noninvasive technology that provides cross-sectional imaging of the tympanic membrane and middle ear. In a clinical trial, OCT changed the diagnosis or treatment plan in 15.3% of children presenting with suspected AOM, particularly those with middle ear effusion without AOM (36% changed) [92]B2b. Its sensitivity for detecting middle ear effusion is 74% with a specificity of 93%, comparable to pneumatic otoscopy and tympanometry [73]C4. Artificial intelligence (AI) classifiers applied to otoscopic images show high sensitivity (96-100%) for classifying abnormal ears, potentially enabling home monitoring and reducing unnecessary visits [11]B2b[110]A1b.
Tissue Sampling and Laboratory Studies
Myringotomy with tympanocentesis remains the gold standard for obtaining middle ear fluid for culture when the diagnosis is uncertain, the patient is critically ill, or when treating refractory or complicated cases. In petrous apicitis, the most frequently cultured pathogen is Pseudomonas (34.2%), followed by Streptococcus and Staphylococcus species [48]C4. In pediatric acute mastoiditis requiring surgery, Fusobacterium necrophorum is the predominant organism (50% of surgical cases) [112]B3b.
Laboratory findings help predict severity. In children with acute mastoiditis, a WBC > 20 K/μL, neutrophil percentage > 67%, and CRP > 17 mg/dL at admission are associated with need for surgical intervention [112]B3b. Eustachian tube function testing via tubomanometry (TMM) may predict medical treatment outcomes in acute otitis media with effusion: a TMM value ≥ 1.5 (sensitivity 72.7%, specificity 74.2%) correlates with a 66.7% response rate to medical therapy, compared with 20.7% for TMM 0-1 [100]B2b.
Diagnostic Algorithm
- Uncomplicated AOM - no imaging; diagnose clinically.
- Suspected complication (persistent fever > 39°C, otorrhea, subperiosteal swelling, neurologic signs, or vertigo) - obtain contrast-enhanced temporal bone CT with or without MRI [112]B3b[113]B2c.
- Incidental mastoid opacification on unrelated imaging - correlate clinically; do not treat unless physical findings of otitis or mastoiditis are present [70]C4[111]C4.
- Refractory or severe infection - perform myringotomy with culture to guide targeted antibiotics [48]C4[112]B3b.
- Consider OCT or AI-assisted imaging as adjuncts in equivocal cases to improve diagnostic certainty [92]B2b[110]A1b.
Handoff to Severity, Staging and Risk Stratification
The imaging and microbiologic findings described here directly inform severity assessment, the extent of bony involvement, presence of abscess or thrombosis, and pathogen identification stratify risk and guide the intensity of medical versus surgical , which is detailed in the next section.
Pearl: In a child with high fever, toxic appearance, and subperiosteal abscess, obtain a contrast-enhanced CT immediately, the combination of WBC > 20 K/μL and CRP > 17 mg/dL predicts a high likelihood of requiring mastoidectomy [112]B3b.
| Modality | Indication | Key Findings | Advantages | Disadvantages |
|---|---|---|---|---|
| Contrast-enhanced CT | Suspected mastoiditis, Luc abscess, sigmoid sinus thrombosis | Mastoid opacification, bony erosion, abscess, filling defects | Rapid, widely available, excellent bone detail | Ionizing radiation; limited soft tissue contrast |
| MRI with gadolinium (+ 3D FLAIR) | Intracranial complications, serous labyrinthitis, dural involvement | Inner ear enhancement (labyrinthitis), thrombus, empyema | Superior soft tissue contrast; no radiation | Longer acquisition time; may require sedation in children |
| OCT | Equivocal middle ear effusion, decision support | Presence/type of effusion (serous vs nonserous) | Noninvasive, real-time, portable | Limited availability; age-dependent image quality (best > 5 years) |
| AI classifier (otoscopic image) | Screening, home monitoring | Automated classification (AOM/OME/normal) | High sensitivity (96-100%); potential for remote care | Requires validated image set; not yet standard of care |
Severity, Staging and Risk Stratification
- ▸Severity grading (mild/moderate/severe) is based on age, fever, otalgia, and tympanic membrane findings; Japanese and Italian guidelines provide structured classification systems.
- ▸Children <2 years with bilateral AOM and children with otorrhea derive greatest benefit from antibiotics (NNT 3-4); observation is appropriate for mild disease in older children.
- ▸Risk factors for recurrence and complications include 22q11.2 deletion (42.2% RAOM), chronic medical conditions (IRR 1.9-2.1 for AOM), and influenza A infection; ET dysfunction alone does not predict phenotype.
Endoscopic and audiologic findings establish the diagnosis; the next step is grading the severity to guide the intensity of . Multiple classification systems have been proposed, all integrating otoscopic assessment with clinical symptoms and age.
Severity Classification Systems
The 2013 Japanese guidelines [127]A1c and their 2018 update [8]D5 categorize AOM into mild, moderate, and severe based on age, fever, otalgia, and tympanic membrane (TM) findings. Accurate otoscopic evaluation is essential because the degree of TM bulging and redness directly determines severity assignment [8]D5[127]A1c.
| Severity | Age | Clinical Symptoms | Otoscopic Findings |
|---|---|---|---|
| Mild | ≥2 years | Fever <38°C, mild otalgia | Localized redness, slight bulging, no otorrhea |
| Moderate | Any age | Fever 38-39°C, moderate otalgia | Diffuse redness, obvious bulging, no otorrhea |
| Severe | <2 years or any age with high risk | Fever ≥39°C, severe otalgia; or age <2 years with bilateral AOM | Marked bulging, intense erythema, or otorrhea |
Adapted from Kitamura et al. 2014 [127]A1c and Hayashi et al. 2020 [8]D5.
The Italian Society of Pediatrics (2019) recommends a similar severity scoring system that combines clinical signs and otoscopic findings to determine whether antibiotic therapy is warranted [123]A1c. In contrast, the AAO-HNS guideline classifies AOM as either severe (moderate-to-severe otalgia, fever ≥39°C, or otorrhea) or nonsevere, with observation appropriate for the latter [125]D5.
Risk Stratification for Treatment Decisions
The individual-patient-data meta-analysis by Rovers et al. identified two subgroups with the largest absolute antibiotic benefit [121]A1a:
- Children with otorrhea (any age): rate difference -36% (95% CI -19% to -53%); NNT = 3 [121]A1a. Children without these features had more modest benefit (NNT = 8), supporting an observational approach for mild, unilateral AOM in older children.
Risk Factors for Recurrence and Complications
Several patient characteristics elevate the risk of recurrent AOM (RAOM) or severe complications:
- : RAOM diagnosed in 42.2% of children, with 38.3% requiring tympanostomy tubes [3]C4.
- Chronic medical conditions (CMCs): Children <19 years with CMCs have an adjusted incidence rate ratio for AOM/sinusitis/NBP of 1.9 (95% CI 1.9-1.9) for one CMC and 2.1 (95% CI 2.1-2.2) for ≥2 CMCs [16]B2b. Immunocompromised children have an IRR of 156.1 (95% CI 133.4-182.7) for invasive pneumococcal disease [16]B2b.
- Influenza A (H1N1) infection: AOM occurred in 33.9% of children with bacterial superinfection, with a median age of 5 years [54]C4.
- Eustachian tube (ET) dysfunction: Both RAOM and chronic otitis media with effusion share similar ET dysfunction patterns; additional factors, such as pathogen-specific inflammatory responses (e.g., higher IL-10 in pneumococcal AOM [130]B2b), likely determine which phenotype develops [129]C4.
Pearl: The presence of bilateral AOM in a child <2 years or otorrhea at any age identifies the subset with the largest absolute antibiotic benefit (NNT 3-4), while otherwise healthy children >2 years with unilateral mild AOM can safely undergo observation; however, children with underlying CMCs or 22q11.2 deletion require a lower threshold for intervention due to markedly elevated recurrence and complication rates.
| Subgroup | Controls with pain/fever at 3-7 days | Antibiotic group with pain/fever at 3-7 days | Absolute risk difference (95% CI) | NNT |
|---|---|---|---|---|
| Age <2 years, bilateral AOM | 55% | 30% | -25% (-36% to -14%) | 4 |
| Otorrhea (any age) | - | - | -36% (-53% to -19%) | 3 |
| No otorrhea | - | - | -14% (-23% to -5%) | 8 |
Acute and Emergency Management
- ▸Immediate analgesia (paracetamol or ibuprofen) is the cornerstone of AOM management; antibiotics provide modest pain reduction at 2-3 days (NNT 20).
- ▸For children <2 years with bilateral AOM or otorrhea, amoxicillin-clavulanate for 10 days is first-line; shorter courses (5 days) are inferior in this age group.
- ▸Complications are rare (0.26% of AOM visits) but require urgent ENT referral; conservative management of acute mastoiditis succeeds in 94% of cases.
Once severity is stratified, the clinician faces a decision: whether to start , initiate watchful waiting, or escalate to surgical drainage. The pathway for acute otitis media (AOM) is guided by age, laterality, severity, and the presence of complications.
Step 1: Initial Assessment and Severity Classification
From the risk-stratification performed in the prior section, classify the episode as:
- Mild to moderate: unilateral, mild otalgia, temperature <39°C, age >2 years, no otorrhea.
- Severe: bilateral, severe otalgia, temperature ≥39°C, age <2 years, or otorrhea present.
For mild-moderate disease in children >2 years, an observational (watchful waiting) strategy is justified, with a safety-net prescription. The 2023 Cochrane meta-analysis confirms that antibiotics do not reduce pain at 24 hours (risk ratio [RR] 0.89, 95% CI 0.78-1.01) but reduce pain at 2-3 days (RR 0.71, 95% CI 0.58-0.88; NNT 20) and at 10-12 days (RR 0.33, 95% CI 0.17-0.66; NNT 7) [55]A1a. For severe disease, immediate antibiotic therapy is indicated.
Step 2: First-Line Medical Management
is the cornerstone. Administer paracetamol (acetaminophen) 15 mg/kg every 4-6 hours or ibuprofen 10 mg/kg every 6-8 hours. Paracetamol may reduce pain at 48 hours (RR 0.38, 95% CI 0.17-0.85; NNT 7; low-certainty evidence) [58]A1a. Topical anaesthetic drops lack sufficient evidence to recommend routinely [60]A1a.
Antibiotics: when to start. In children 6-23 months with severe disease (bilateral AOM or otorrhea), immediate antibiotics are warranted. for 10 days reduced clinical failure from 23% to 4% at day 4-5 in a placebo-controlled trial (P<0.001) [47]A1b. In children 6-35 months, -clavulanate reduced treatment failure from 44.9% to 18.6% (hazard ratio 0.38, 95% CI 0.25-0.59) [1]A1b.
| Drug | Starting dose | Target / max dose | Duration | Key monitoring |
|---|---|---|---|---|
| Amoxicillin-clavulanate | 45 mg/kg/day amoxicillin component PO divided BID | 90 mg/kg/day for severe disease | 10 days (7 days if age ≥6 years) | Diarrhea, rash; reduce dose if renal impairment |
| Cefdinir (penicillin-allergic, non-severe) | 14 mg/kg/day PO divided once or BID | Same | 10 days | Monitor for diarrhea; 1% cross-reactivity with penicillin |
| (parenteral) | 50 mg/kg IM/IV once daily | Same | 1-3 days | Pain at injection site; may switch to oral after defervescence |
For patients with a non-severe IgE-mediated , cefdinir is guideline-recommended [149]D5.
Step 3: Escalation, Treatment Failure and Surgical Referral
If symptoms worsen or fail to improve after 48-72 hours of first-line therapy:
- Re-examine: confirm diagnosis, check for complications (mastoiditis, facial nerve palsy, labyrinthitis).
- For severe or persistent disease, switch to ceftriaxone 50 mg/kg IM/IV daily for 3 days, then oral step-down.
- Myringotomy ± tympanostomy tube is indicated for toxic children with severe otalgia, or when otorrhea persists despite topical therapy [144]D5.
- In children with tympanostomy tubes and acute tube otorrhea, topical 0.3% plus fluocinolone 0.025% is superior to ciprofloxacin alone: clinical cure 80.6% vs 67.4%, and median time to otorrhea cessation 4.23 days vs 6.95 days (P<0.001) [137]A1b.
Complications require urgent ENT consultation. , though rare (0.16% of AOM visits [90]B2c), may present with postauricular swelling, erythema, and auricular protrusion. Conservative management (IV antibiotics ± needle aspiration) succeeds in 94% of cases, with secondary mastoidectomy reserved for failures [161]C4. Petrous apicitis presents with Gradenigo's triad (abducens palsy, otorrhea, retro-orbital pain) in only 21% of cases; management includes IV antibiotics and surgical drainage [48]C4. Facial nerve palsy from AOM has a good prognosis without nerve decompression [77]C4.
Step 4: Monitoring and Titration
- Pain and fever: reassess at 48-72 hours. If resolved, complete the antibiotic course.
- Hearing: perform audiometry if sensorineural hearing loss is suspected ( , vertigo, high-frequency loss). AOM in adults may cause SNHL in 9.3% of cases, commonly at high frequencies [84]C4.
- Recurrence: if ≥3 episodes in 6 months or ≥4 in 12 months, refer for tympanostomy tube evaluation. The 2021 NEJM trial found no significant difference in AOM rate between tubes and medical management (1.48 vs 1.56 episodes per child-year) but tubes reduced treatment failure and improved parent satisfaction [138]A1b.
Step 5: Disposition and Transition
Most children can be managed outpatient. Admission is warranted for: toxic appearance, age <6 months, suspected suppurative complication, or inability to tolerate oral antibiotics. Once the acute episode resolves, assess for persistent middle-ear effusion and manage per the OME guideline. For children with recurrent AOM, the next section addresses definitive surgical vs medical strategies.
Controversies and Guideline Disagreement
| Question | Position A | Position B | Strength | Implication for practice |
|---|---|---|---|---|
| Immediate antibiotics vs watchful waiting for mild AOM | AAO-HNS endorses watchful waiting for non-severe, unilateral AOM in children >2 years [44]C4 | Cochrane confirms antibiotics reduce pain at 2-3 days (NNT 20) but increase adverse events [55]A1a | Moderate | Use shared decision-making; prescribe a safety-net antibiotic for delayed use. |
| Shorter vs standard antibiotic duration (5 vs 10 days) | Hoberman 2016 (NEJM) and Benkendorff 2026 systematic review: 5-day courses are inferior (clinical failure 34% vs 16%) [139]B2b[157]A1a | Some European guidelines consider 5-7 days acceptable for mild cases in older children | Strong (for <2 years) | For children <2 years, complete a 10-day course; shorter durations risk undertreatment. |
What NOT to do:
- Do not prescribe antihistamines or decongestants for AOM or OME; they provide no benefit and increase harm (NNT to harm = 9) [154]A1a.
- Do not use oral or nasal corticosteroids for OME [153]A1a or antibiotics for OME [59]A1a.
- Do not treat AOM with antireflux therapy; randomized trials show no benefit [135]B2a.
Pearl: Initiate analgesia immediately for all children with AOM; reserve antibiotics for those <2 years with bilateral disease or otorrhea, as these subgroups derive the greatest absolute benefit (NNT 3-4) [121]A1a. For severe or treatment-refractory cases, do not delay myringotomy or IV antibiotics to avert complications.
| Agent | Dose | Frequency | Evidence level |
|---|---|---|---|
| Paracetamol (acetaminophen) | 15 mg/kg PO/PR | Every 4-6 hours | NNT 7 at 48 h (low certainty) [58]A1a |
| Ibuprofen | 10 mg/kg PO | Every 6-8 hours | No direct RCT in AOM; effective for fever/otalgia |
| Topical anaesthetic drops (benzocaine) | Not recommended | , | Insufficient evidence [60]A1a |
Medical versus Surgical Management (Definitive)
- ▸Tympanostomy tubes do not reduce the AOM episode rate compared with medical management in the largest RCT (N=509), but improve secondary outcomes and quality of life.
- ▸Concurrent adenoidectomy at initial tube placement reduces the risk of repeat tube insertion by nearly half (OR 0.46), especially in children ≥4 years.
- ▸Standard 10-day amoxicillin-clavulanate is superior to 5-day therapy (clinical failure 34% vs 16%); antihistamines/decongestants and corticosteroids have no role in OME management.
For children who have completed initial treatment for an acute episode, the decision to pursue definitive medical or surgical depends on the pattern of recurrence, presence of middle ear effusion (MEE), and impact on quality of life.
Step 1: Eligibility Assessment
Document whether the child meets criteria for recurrent AOM (≥3 episodes in 6 months or ≥4 in 12 months) or chronic otitis media with effusion (OME) lasting ≥3 months. Confirm MEE at the time of assessment using tympanometry or pneumatic otoscopy. The AAO-HNS 2022 guideline recommends not performing tympanostomy tube insertion in children with recurrent AOM who lack MEE at the evaluation visit [133]A1c [166]A1c. In a case series adhering to this rule, 91% of children without MEE did not require tubes within one year [173]C4.
Step 2: Medical Management Options
- Observation with is appropriate for mild, infrequent episodes; about 55% of untreated AOM resolves spontaneously [1]A1b.
- Standard 10-day reduces treatment failure compared with placebo (18.6% vs 44.9%; HR 0.38, 95% CI 0.25-0.59; NNT 4) [1]A1b. Diarrhea occurs in 47.8% vs 26.6% (p<0.001). Shortened 5-day courses result in higher clinical failure (34% vs 16%; difference 17 percentage points, 95% CI 9-25) [139]B2b.
- Topical therapy for tympanostomy tube otorrhea: plus otic solution twice daily for 7 days is superior to ciprofloxacin alone (median time to cessation 4.23 vs 6.95 days; clinical cure 80.6% vs 67.4%; p=0.002) [137]A1b. For AOM with ear discharge in children without tubes, limited data suggest oral may be more effective than antibiotic-corticosteroid eardrops (65% vs 42% resolution at day 3), though eardrops reduce systemic antibiotic use [186]A1b.
Step 3: Surgical Options
- insertion is indicated for recurrent AOM with MEE or chronic OME with hearing loss. In the largest randomized trial (N=509), the mean AOM rate per child-year over 2 years was not significantly different between tubes and medical management (1.48 vs 1.56 episodes; P=0.66 in intention-to-treat; 1.47 vs 1.72 in per-protocol analysis) [138]A1b. However, secondary outcomes favored tubes: time to first episode, clinical findings, and treatment failure. Tubes improve otitis-media-specific quality of life [124]B2c.
- Myringotomy alone is not recommended as definitive management for recurrent AOM.
Step 4: Treatment Algorithm
Figure 1: Treatment algorithm for definitive management of recurrent AOM and chronic OME (adapted from AAO-HNS 2022 guideline [133]A1c).
Table: Medical vs Surgical Options for Definitive Management
| Option | Indication | Key Evidence | Outcome | Evidence Level |
|---|---|---|---|---|
| Observation with analgesia | Mild, infrequent AOM | Spontaneous resolution ~55% [1]A1b | Avoids antibiotic side effects; risk of progression | 1b |
| Standard 10d amoxicillin-clavulanate | First-line AOM therapy | Treatment failure 18.6% vs 44.9%; HR 0.38; NNT 4 [1]A1b | Effective; diarrhea 47.8% | 1b |
| Short-course (5d) | Not recommended | Clinical failure 34% vs 16% for 10d; NNT 6 for failure [139]B2b | Inferior to 10d course | 2b |
| Antimicrobial prophylaxis | Pre-PCV, marginal benefit | RR 0.59 (0.45-0.77) [191]A1a | AOM reduction; resistance risk | 1a |
| Topical ciprofloxacin-fluocinolone | Tube otorrhea | Median cessation 4.23 vs 6.95 days; clinical cure 80.6% [137]A1b | Superior to antibiotic alone | 1b |
| Tympanostomy tubes | RAOM with MEE or chronic OME | AOM rate 1.48 vs 1.56 ep/child-yr (NS) [138]A1b; improved QoL [124]B2c | No difference in AOM rate; secondary benefit | 1b |
| TT + adenoidectomy | Age ≥4, prior TT | Repeat TT 17.2% vs 31.8%; OR 0.46 [120]A1a[168]B2a | Reduces need for repeat surgery | 1a |
Controversies and Guideline Disagreement
| Question | Position A | Position B | Strength | Implication for practice |
|---|---|---|---|---|
| Tympanostomy tubes for RAOM without MEE | AAO-HNS 2022, do not insert tubes in children with RAOM without MEE at time of assessment [133]A1c [166]A1c | Some clinicians may offer tubes based on history alone despite guideline | Strong (recommendation) | Adherence to CPG avoids unnecessary surgery; 91% of such children did not require tubes within 1 year [173]C4 |
| Role of antibiotics for AOM with ear discharge | Limited Dutch data suggest oral amoxicillin may be more effective than eardrops (65% vs 42% resolution at day 3) [186]A1b | AAO-HNS guidelines recommend topical antibiotics only for uncomplicated TT otorrhea [133]A1c | Moderate (different populations) | For children without tubes, oral antibiotics remain first-line; topical reserved for tube otorrhea |
What NOT to Do
- Do NOT use antihistamines or decongestants for AOM or OME, no benefit and increased side effects (NNH 9) [154]A1a [176]A1a [177]A1a.
- Do NOT use oral or for OME in children, no improvement in hearing or resolution [153]A1a.
- Do NOT perform myringotomy alone for recurrent AOM, not superior to no surgery.
Pearl: For children with recurrent AOM, tympanostomy tube placement should be reserved for those with documented middle ear effusion at the time of assessment; tubes do not reduce the overall episode rate but may improve clinical course and quality of life, and concurrent adenoidectomy should be considered in children ≥4 years to reduce the need for repeat surgery [138]A1b [120]A1a [168]B2a.
History and Evolution of Treatment
- ▸Antibiotics provide a 12.3% absolute benefit over placebo in AOM; NNT = 8 to prevent one clinical failure, but benefit is greater in children <2 years with severe symptoms (NNT = 4-5).
- ▸Ten-day amoxicillin-clavulanate is superior to 5-day therapy in children <2 years (34% vs 16% clinical failure).
- ▸Vaccination (PCV with protein D) reduces all-cause AOM by up to 34%, while decongestants, antihistamines, xylitol, and non-targeted probiotics have no proven benefit.
Several landmark trials have shaped the modern treatment of acute otitis media, establishing the evidence for , refining their duration, and defining the role of surgical intervention.
The Antibiotic Era and Its Questioning
Early randomized trials set the stage. Van Buchem et al. (1981) found no significant differences in clinical course among children treated with myringotomy, antibiotics, both, or neither, with symptomatic therapy alone appearing reasonable [212]A1b. Engelhard et al. (1989) demonstrated that ("augmentin") was more effective than myringotomy plus placebo, with 60% complete otoscopic recovery versus 23% [215]A1b.
The Agency for Healthcare Research and Quality evidence report (2001) pooled 5 placebo-controlled trials and found a clinical success rate of 81% at 1 to 7 days with placebo or no antimicrobial, and a 12.3% absolute increase with or ; about 8 children must receive antibiotics to avoid one clinical failure [218]D5. Subsequent placebo-controlled trials in children aged 6 to 35 months (Tähtinen 2011) and 6 to 23 months (Hoberman 2011) confirmed that amoxicillin-clavulanate significantly reduced treatment failure (18.6% vs 44.9%; HR 0.38; NNT = 4) and clinical failure (4% vs 23% at day 4-5; NNT = 5), respectively [1]A1b[47]A1b. A natural-history meta-analysis (Rosenfeld & Kay 2003) reported spontaneous symptom improvement within 24 hours without antibiotics in 61% of children, rising to 80% by 2 to 3 days, with suppurative complications comparable whether antibiotics were withheld (0.12%) or provided (0.24%) [205]A1a.
Duration of Therapy
The optimal duration of antibiotics was tested in a landmark noninferiority trial by Hoberman et al. (2016). Among children aged 6 to 23 months with AOM, 5 days of amoxicillin-clavulanate was inferior to 10 days, with clinical failure rates of 34% vs 16% (difference 17 percentage points; NNT = 6 for harm of shorter course) [139]B2b. This trial established that 10-day therapy remains standard for children under 2 years, a recommendation affirmed by the 2025 Italian intersociety consensus, which also endorses a 5-day course for selected mild cases based on watchful waiting [2]A1c.
Watchful Waiting and Shared Decision-Making
Watchful waiting, endorsed by multiple guidelines, is supported by the high spontaneous resolution rates documented in the natural-history literature [205]A1a. A 2025 randomized emergency-department trial of a web-based decision aid (Ear Pain Decision Aid) improved parental knowledge without increasing interaction time, though immediate antibiotic prescribing did not significantly differ [185]A1b. Shared decision-making, particularly for non-severe AOM, can align parental preferences with evidence-based care.
Surgical : Tympanostomy Tubes
The role of tympanostomy tubes for recurrent AOM has evolved. Gonzalez et al. (1986) randomized children to tympanostomy tubes, sulfisoxazole prophylaxis, or placebo; tube insertion significantly reduced treatment failure (23% vs 60% in placebo) [207]A1b. However, the more recent Hoberman et al. (2021) trial compared tympanostomy tubes to medical management in children aged 6 to 35 months with recurrent AOM and found no significant difference in the rate of AOM episodes over 2 years (1.48 vs 1.56 per child-year; P=0.66), though some secondary outcomes favored tubes [138]A1b. A 2018 Cochrane review noted that grommet insertion leads to a mean reduction of 1.5 episodes in the first 6 months, but long-term benefits are uncertain [181]A1a.
For acute tympanostomy tube otorrhea, topical antibiotic-corticosteroid drops are superior to antibiotics alone. Roland et al. (2003) showed / reduced time to cessation of otorrhea by 1.09 days vs ciprofloxacin alone [208]A1b. Spektor et al. (2017) demonstrated that ciprofloxacin plus fluocinolone achieved faster cessation (median 4.23 vs 6.95 days) and higher clinical cure (80.6% vs 67.4%) [137]A1b.
Vaccine Impact
Pneumococcal conjugate vaccines (PCVs) have modestly reduced all-cause AOM. The 7-valent PCV (CRM197 carrier) reduced all-cause AOM by 6% (95% CI, -4% to 16%) in low-risk infants [209]A1b. The 11-valent PCV with H. influenzae protein D as carrier reduced all-cause AOM by 33.6% (95% CI, 20.8% to 44.3%) and also reduced episodes from non-typeable H. influenzae by 35.3% [140]A1b. Influenza vaccine provides a small reduction in AOM episodes (RR 0.80; 95% CI, 0.67 to 0.96; NNT = 25) [220]A1a[221]A1a. Serotype replacement has partially offset PCV benefits [214]A1b.
Abandoned or Ineffective Therapies
Several once-common interventions have been abandoned due to lack of efficacy or adverse effects. The table below summarizes key therapies that clinical trials have demonstrated to be ineffective or harmful.
| Intervention | Key Evidence | Conclusion |
|---|---|---|
| Decongestants and antihistamines | Cochrane review (15 trials, 2695 children): no benefit for early cure or symptom resolution; 5- to 8-fold increased side effects [176]A1a[183]A1a | Do not recommend |
| Xylitol (2 times/day) | RCT in children 1-5 years: no reduction in AOM episodes (OR 2.04; 95% CI, 0.43-12.92) [230]A1b | Not effective |
| S. salivarius K12 for primary prevention | RCT in 827 children: 8.2% vs 5.8% with AOM (RR 1.42; 95% CI, 0.86-2.34) [229]A1b | Not effective |
| Antibiotic prophylaxis (sulfisoxazole) | Gonzalez 1986: trend toward fewer AOM episodes but not statistically significant; routine prophylaxis raises resistance concerns [207]A1b | Not recommended for routine use |
Pearl: The cumulative evidence shows that 8 children need antibiotics to prevent one clinical failure, but vaccination strategies have reduced the overall burden of AOM by up to 34%. In young children with severe AOM, 10-day amoxicillin-clavulanate remains the evidence-based standard; watchful waiting and shared decision-making are appropriate for non-severe cases.
Controversies and Guideline Disagreement
| Question | Position A | Position B | Strength | Implication |
|---|---|---|---|---|
| Antibiotic duration in children <2 years | AAO-HNS, AAP: 10 days [139]B2b | Italian intersociety consensus: 5 days for mild cases [2]A1c | Weak | 10-day course is standard for young children with severe AOM; 5-day may be considered for mild, uncomplicated cases after watchful waiting |
| Trial/Reference | Year | Intervention | Key Finding |
|---|---|---|---|
| van Buchem [212]A1b | 1981 | Myringotomy, antibiotics, both, or neither | No difference in clinical course; symptomatic therapy alone is reasonable |
| Engelhard [215]A1b | 1989 | amoxicillin-clavulanate vs myringotomy + placebo | 60% vs 23% recovery with augmentin |
| AHRQ Evidence Report [218]D5 | 2001 | Placebo vs antibiotics | Placebo success 81%; antibiotics add 12.3% (NNT = 8) |
| Tähtinen [1]A1b | 2011 | Amoxicillin-clavulanate vs placebo in 6-35 mo | Treatment failure 18.6% vs 44.9% (HR 0.38; NNT = 4) |
| Hoberman [47]A1b | 2011 | Amoxicillin-clavulanate vs placebo in 6-23 mo | Clinical failure 4% vs 23% at day 4-5 (NNT = 5) |
| Hoberman [139]B2b | 2016 | 5-day vs 10-day amoxicillin-clavulanate in 6-23 mo | 5-day inferior: 34% vs 16% clinical failure (NNT = 6 for harm) |
| Eskola [209]A1b | 2001 | PCV7 | 6% reduction in all-cause AOM; 34% reduction in pneumococcal AOM |
| Prymula [140]A1b | 2006 | 11-valent PCV with protein D | 34% reduction in all-cause AOM; also targets non-typeable H. influenzae |
| Roland [208]A1b | 2003 | Topical ciprofloxacin/dexamethasone vs ciprofloxacin | 1.09-day faster cessation of otorrhea |
| Spektor [137]A1b | 2017 | Topical ciprofloxacin/fluocinolone vs ciprofloxacin | Median cessation 4.23 vs 6.95 days; clinical cure 80.6% vs 67.4% |
| Hoberman [138]A1b | 2021 | Tympanostomy tubes vs medical management for rAOM | No significant difference in AOM rate (1.48 vs 1.56 per year) |
| Intervention | Key Evidence | Conclusion |
|---|---|---|
| Decongestants/antihistamines | Cochrane: no benefit, 5-8× side effect risk [176]A1a[183]A1a | Do not recommend |
| Xylitol twice daily | RCT: no reduction in AOM (OR 2.04) [230]A1b | Not effective |
| S. salivarius K12 probiotics | RCT: 8.2% vs 5.8% AOM (RR 1.42) [229]A1b | Not effective for primary prevention |
| Antibiotic prophylaxis | Trend toward benefit but not significant; resistance concerns [207]A1b | Not routinely recommended |
Surgical Technique, Approaches and Perioperative Care
- ▸Tympanostomy tube insertion is the most common pediatric ambulatory surgery; anterior and posterior quadrant placement yield similar early hearing and extrusion outcomes.
- ▸Adjuvant adenoidectomy reduces repeat tympanostomy tube risk by nearly half (OR 0.46), particularly in children older than 4 years.
- ▸Conservative management of acute mastoiditis with subperiosteal abscess (IV antibiotics, myringotomy, needle aspiration) avoids cortical mastoidectomy in >90% of pediatric cases.
The evolution of treatment from watchful waiting to surgical intervention has refined the indications and techniques for tympanostomy tube placement, adenoidectomy, and of suppurative complications. This section details the operative specifics that govern outcomes in acute otitis media (AOM) and its sequelae.
Tympanostomy Tube Insertion
Myringotomy with tube placement is the most common ambulatory surgery in US children [133]A1c. The incision is made in the tympanic membrane; anterior inferior (AI) and posterior inferior (PI) quadrant placement show no significant differences in hearing, tube extrusion, or function at 3-month follow-up [94]A1b. Tube patency is more reliably assessed in AI placements (3.5% non-visualized vs 41.9% for PI) [94]A1b. Tube type matters: phosphorylcholine-coated fluoroplastic tubes offer no advantage over uncoated standard tubes in otorrhea, blockage, or extrusion rates [169]A1b. Long-term tubes reduce the odds of repeat tube placement (OR 0.27) [168]B2a.
Perioperative care centers on managing tube otorrhea. For acute tympanostomy tube otorrhea (AOMT), topical 0.3% plus fluocinolone 0.025% otic solution twice daily for 7 days is superior to ciprofloxacin alone: median time to cessation 4.23 days vs 6.95 days (P < .001), clinical cure 80.6% vs 67.4% (difference 13.2%, P = .002) [137]A1b. Oral are not indicated for uncomplicated AOMT [133]A1c. Systemic antibiotics are reserved for cases with severe infection, fever, or failure of topical therapy.
Indications for tube placement follow AAO-HNS guidelines: bilateral OME for ≥3 months with documented hearing difficulties, or recurrent AOM (≥3 episodes in 6 months or ≥4 in 12 months) [133]A1c. The landmark NEJM trial found no significant difference in AOM rate over 2 years between tubes and medical management (1.48 vs 1.56 per child-year, P = 0.66), but secondary outcomes including time to first episode and treatment failure favored tubes [138]A1b. About 1 in 4 children will receive at least one repeat set of tubes (24.1%, 95% CI 18.2%-29.9%) [168]B2a. Risk factors for repeat placement include younger age at initial surgery, craniofacial disease (OR 5.13), and shorter tube retention time [168]B2a. Intraoperative middle ear effusion, especially purulent, increases odds of in-office (OR 2.13) [187]C4.
Adenoidectomy as Adjuvant
Adenoidectomy at initial tympanostomy tube placement reduces the risk of repeat surgery: estimated repeat TT rate 17.2% with adenoidectomy vs 31.8% with TT alone [120]A1a. The protective effect is strongest in children older than 4 years; in younger children the benefit is diminished [120]A1a. Adenoidectomy also reduces recurrent AOM and otorrhea (OR 0.46, 95% CI 0.39-0.55 for repeat TT) [168]B2a. In cleft palate children, limited historical data suggest benefit for conductive hearing loss and recurrent OM, but modern conservative (endoscopic, partial) techniques remain unstudied [143]B2a. Adenoid biofilms may contribute to recurrent AOM and chronic OM, supporting mechanical removal [245]B2a.
Balloon Dilation of the Eustachian Tube (BDET)
For children with chronic refractory to prior surgery (adenoidectomy, tubes), BDET offers a safe and durable option. In a pooled analysis of 219 patients (425 ears), 1-year failure-free probability was 93.8% (95% CI 89.7%-) and 2-year probability 87.2% (95% CI 81.9%-91.0%); tympanograms improved in 83.7% of ears; minor adverse events occurred in 5.9% [147]B3b. BDET is typically combined with myringotomy or tympanoplasty as needed [99]C4.
Surgical Management of Complications
with subperiosteal abscess can often be managed conservatively. In a series of 73 children (26 with abscess), initial treatment with IV antibiotics, myringotomy, and needle aspiration or incision of the abscess led to resolution in 94% of cases; only 8% required secondary mastoidectomy [161]C4. For subperiosteal abscess without intracranial extension, incision and drainage plus myringotomy yields similar length of stay (median 5 days) and fewer complications compared with cortical mastoidectomy (median 5.5 days, 2 complications vs 0) [243]B2b. Cortical mastoidectomy remains indicated for intracranial complications, failure of conservative therapy, or suspected .
Petrous apicitis requires aggressive surgical drainage: 67.9% of 134 patients underwent surgery ranging from myringotomy (26.9%) to petrosectomy (25.4%); mortality was 5.7% [48]C4. Facial nerve paralysis due to AOM generally has a good prognosis without surgical decompression [77]C4. Intracranial empyema of otogenic origin (O-IE) occurs in younger children (mean 40 months), is predominantly extradural (96%), and most commonly yields Fusobacterium necrophorum; ENT surgery is required in 95% of cases, neurosurgery in 7%; cerebral venous thrombosis complicates 55% [241]B2b.
Perioperative Care in Special Populations
Cochlear implant recipients with pre-existing ventilation tubes: retaining the tube during implantation reduces post-CI AOM at 6 months (0% vs 20.5%, P = 0.044) [20]B2b. After CI, AOM in the first 2 months should be treated with parenteral antibiotics (e.g., ); after 2 months, high-dose is appropriate [164]D5. (PCV13 and PPSV23) is mandatory before CI [164]D5. Delayed swelling around the implant occurs in 5.5% of patients (9.8% of children), often due to trauma or AOM; conservative management suffices in 91.4% [91]B2b.
Pearl: For acute tube otorrhea, topical ciprofloxacin-fluocinolone drops are first-line, reducing median otorrhea duration by 2.7 days compared with antibiotic alone [137]A1b. In acute mastoiditis with subperiosteal abscess, initial conservative surgery (myringotomy plus needle aspiration) avoids mastoidectomy in over 90% of children [161]C4.
| Intervention | Success Rate | Length of Stay (median) | Complications |
|---|---|---|---|
| Incision & drainage + myringotomy | 92% (no secondary mastoidectomy) | 5 days | 0% [243]B2b |
| Cortical mastoidectomy | 100% (primary) | 5.5 days | 2/32 (6.3%) [243]B2b |
| Conservative (IV abx + myringotomy ± needle aspiration) | 94% resolution | 2.9 days | 1.4% [161]C4 |
Complications
- ▸Complications of AOM are rare (0.26% of ED visits) but can be severe; acute mastoiditis is the most common
- ▸High fever, leukocytosis, and subperiosteal abscess predict need for surgical mastoidectomy
- ▸Treatment-related harms, antibiotic adverse events (NNH=20) and post-tympanostomy otorrhea (4-18%), must be balanced against benefit
The surgical approaches detailed in the preceding section effectively manage uncomplicated AOM and its sequelae, but both the disease and its interventions carry well-defined adverse outcomes. Complications of AOM are classified as intratemporal or intracranial, and treatment-related harms must be weighed against therapeutic benefits.
Intratemporal Complications
is the most common suppurative complication, occurring in approximately 0.16% of AOM-related emergency department visits [90]B2c. Among children hospitalized for acute mastoiditis, 14% require cortical mastoidectomy; factors predicting surgical intervention include high fever (mean 39.2°C), leukocytosis (mean WBC 20 K/µL), and elevated CRP (mean 17 mg/dL) [112]B3b. Fusobacterium necrophorum is the predominant pathogen in surgical cases (50%) [112]B3b. For mastoiditis with subperiosteal abscess but no intracranial extension, incision and drainage with myringotomy achieves comparable outcomes to mastoidectomy, with a median length of stay of 5 days and no difference in complications [243]B2b. Petrous apicitis is rare (mean age 33 years); only 20.9% present with the classic Gradenigo triad of abducens palsy, otorrhea, and retro-orbital pain, and mortality is 5.7% [48]C4. Facial nerve paresis occurs in 0.03% of AOM visits [90]B2c, labyrinthitis in 0.06%, and sensorineural hearing loss may persist at extended high frequencies even after the first episode [72]B2b.
Intracranial Complications
Otogenic intracranial empyema is predominantly extradural (96%) and affects younger children (mean age 40 months). Fusobacterium necrophorum is isolated in 47% of cases; cerebral venous thrombosis complicates 55% of otogenic empyemas, and neurological disability occurs in 8% of survivors [241]B2b. , meningitis, and sinus vein thrombosis are more frequent in adults than children (87% vs 17%) [162]C4.
Treatment-Related Complications
Tympanostomy tube placement carries a risk of postoperative otorrhea: 4% with titanium tubes versus 18% with fluoroplastic tubes [251]C4; biofilms contribute in 60% of refractory cases [148]C4. Repeat tube insertion is required in 17.2% of children when adenoidectomy is performed concurrently, compared to 31.8% with tubes alone, though the benefit is diminished under age 4 years [120]A1a. Antibiotic therapy for AOM increases and cutaneous adverse events (RR 1.38, 95% CI 1.14-1.68; NNT for harm = 20) [55]A1a. Antimicrobial chemoprophylaxis for recurrent AOM reduces episodic risk (RR 0.59) but is based on pre-pneumococcal conjugate vaccine data and contributes to resistance [191]A1a.
| Complication | Population Frequency | Prevention | |
|---|---|---|---|
| Acute mastoiditis | 0.16% of AOM ED visits [90]B2c | Prompt AOM treatment; | IV ± myringotomy; cortical mastoidectomy if abscess or refractory [112]B3b |
| Intracranial empyema | <0.01% | Treat AOM/mastoiditis early | Neurosurgical drainage + ENT source control; IV antibiotics [241]B2b |
| Facial nerve paresis | 0.03% [90]B2c | Not specifically preventable | Treat underlying AOM; corticosteroids of uncertain benefit |
| Post-tympanostomy tube otorrhea | 4-18% [251]C4 | Titanium tubes; biofilm-directed strategies | Topical antibiotic drops; debris removal [148]C4 |
| Antibiotic adverse events | RR 1.38 [55]A1a | Judicious prescribing | Symptomatic management; NNH = 20 |
Pearl: The single most important step to prevent AOM complications is early recognition of mastoiditis, the presence of high fever, leukocytosis, and a subperiosteal abscess on exam or CT should prompt urgent ENT consultation, as delays increase the need for mastoidectomy and the risk of intracranial spread [112]B3b[90]B2c.
Prognosis and Natural History
- ▸Spontaneous resolution occurs in 60% of children within 24 hours, but antibiotics reduce pain and clinical failure substantially in young children, especially those <2 years with bilateral or severe disease.
- ▸Recurrence is frequent: 24% of children receiving tympanostomy tubes require repeat placement; adenoidectomy and long-term tubes lower that risk.
- ▸Even a single AOM episode can cause persistent elevated thresholds in extended high frequencies (8-16 kHz), and pneumococcal vaccination has reduced AOM-related admissions by 34%.
Complications of acute otitis media, though rare when they occur, highlight the importance of understanding the disease's natural history and the measurable benefits of treatment.
Untreated Trajectory
Spontaneous resolution is the rule. In placebo groups of randomized trials, 60% of children had recovered by 24 hours from symptom onset [62]A1a. By 2-3 days, residual pain affected roughly a third of untreated children, declining further over the following week [62]A1a. Tympanic membrane perforation occurred in a small proportion (placebo event rate approximately 3-4%), and contralateral AOM developed in about 10% [62]A1a. Progression to is uncommon, admission for AOM complications decreased from 3.956 to 2.618 per 100,000 persons between 2000 and 2012 (34% relative risk reduction), attributed largely to [237]B2c. When mastoiditis does develop, conservative initial (needle aspiration or incision) leads to resolution in 94% of cases without mastoidectomy [161]C4.
Treated Outcomes with
Antibiotics accelerate symptom resolution. At 2-3 days, pain was reduced by almost a third compared with placebo (RR 0.70; NNT 20), at 4-7 days (RR 0.76; NNT 16), and at 10-12 days (RR 0.33; NNT 7) [62]A1a. Tympanic membrane perforations were halved (RR 0.37; NNT 33) and contralateral AOM episodes reduced by half (RR 0.49; NNT 11) [62]A1a. Abnormal tympanometry at 2-4 weeks was also less common (RR 0.82; NNT 11), but this benefit did not persist at 3 months (RR 0.97) [62]A1a. Adverse events, diarrhea, vomiting, rash, were more frequent with antibiotics (RR 1.34; NNTH 14) [62]A1a.
In children aged 6-23 months diagnosed with stringent criteria, 10 days of lowered clinical failure from 23% to 4% at day 4-5 (NNT 5) and from 51% to 16% at day 10-12 (NNT 3) [47]A1b. Another trial reported treatment failure of 18.6% with -clavulanate versus 44.9% with placebo (NNT 4) [1]A1b. Shortened antibiotic courses (5 vs 10 days) increased failure from 16% to 34% (difference 17 percentage points) in children <2 years and did not reduce adverse events [139]B2b.
Recurrence and Long-term Surgery
Recurrent AOM is common even after treatment; antibiotics do not reduce late recurrences (RR 0.93) [62]A1a. Among children receiving tympanostomy tubes, 24.1% undergo at least one repeat tube placement and 7.5% undergo three or more procedures [168]B2a. Predictors of repeat surgery include craniofacial disease (OR 5.13), younger age at first tube, and shorter tube retention time [168]B2a. Primary adenoidectomy at initial tube placement reduces the odds of repeat surgery (OR 0.46), and long-term tubes are even more protective (OR 0.27) [168]B2a.
Hearing and Quality of Life
Even a single episode of AOM can produce persistent elevation of extended high-frequency thresholds (8-16 kHz) that lasts at least 6 months [72]B2b. Persistent at 6 months is associated with more severe hearing loss in those frequencies [72]B2b. After mastoidectomy, long-term audiometry shows a median ~10 dB elevation in high frequencies and worse patient-reported outcomes for hearing, tinnitus, and ear discomfort [32]C4. Children with recurrent OM have significantly worse health-related quality of life (OM-6 mean 3.3 vs 2.5 in healthy peers); tube placement is associated with better scores [124]B2c.
Prognostic Factors
Nasopharyngeal colonization with Streptococcus pneumoniae or at diagnosis approximately doubles the odds of clinical failure despite antibiotics (OR 1.8) [253]A1b. Children with bilateral AOM, those exposed to ≥3 other children for ≥10 hours/week, and those <2 years of age have higher failure rates [139]B2b. Low-birth-weight and preterm children are not at increased risk for severe mastoiditis but preterm children are more prone to recurrent episodes with shorter intervals between them [85]B2b.
Impact of Prevention
Pneumococcal conjugate vaccines have reduced AOM-related hospitalizations by 34% and pneumococcal meningitis in the setting of AOM by a similar magnitude [237]B2c. Serotype replacement and antibiotic resistance remain ongoing challenges [22]D5.
Pearl: Although 60% of children with AOM recover within 24 hours regardless of treatment, antibiotics provide a 23-26% absolute risk reduction for clinical failure in children under 2 years, NNT of 5 to prevent failure at day 4-5 and NNT 4 at day 10-12 [47]A1b[1]A1b; the benefits come at the cost of one additional adverse event for every 14 children treated [62]A1a.
| Outcome | Time point | RR (95% CI) | NNTB (95% CI) | Source |
|---|---|---|---|---|
| Pain resolution | 24 hours | 0.89 (0.78-1.01) | Not significant | [62]A1a |
| Pain resolution | 2-3 days | 0.70 (0.57-0.86) | 20 | [62]A1a |
| Pain resolution | 4-7 days | 0.76 (0.63-0.91) | 16 | [62]A1a |
| Pain resolution | 10-12 days | 0.33 (0.17-0.66) | 7 | [62]A1a |
| Tympanic membrane perforation | variable | 0.37 (0.18-0.76) | 33 | [62]A1a |
| Contralateral AOM | variable | 0.49 (0.25-0.95) | 11 | [62]A1a |
| Abnormal tympanometry | 2-4 weeks | 0.82 (0.74-0.90) | 11 | [62]A1a |
| Abnormal tympanometry | 3 months | 0.97 (0.76-1.24) | Not significant | [62]A1a |
| Late AOM recurrence | 3+ months | 0.93 (0.78-1.10) | Not significant | [62]A1a |
| Any adverse event (diarrhea, rash) | treatment period | 1.34 (1.16-1.55) | NNTH 14 | [62]A1a |
| Clinical failure (age <2 y, stringent criteria) | Day 4-5 | 4% vs 23% (ARR 19%) | 5 | [47]A1b |
| Clinical failure (age <2 y) | Day 10-12 | 16% vs 51% (ARR 35%) | 3 | [47]A1b |
Special Populations and Pregnancy
- ▸Children <2 years with bilateral acute otitis media derive the greatest antibiotic benefit (NNT=4 to prevent persistent symptoms at 3-7 days) [121].
- ▸Pregnancy allows safe use of amoxicillin and cephalosporins; tetracyclines and fluoroquinolones are contraindicated.
- ▸Elderly and immunocompromised patients have higher complication rates; a lower threshold for aggressive antimicrobial therapy, imaging, and surgical drainage is essential.
Prognosis hinges on host factors, and several populations demand modified diagnostic thresholds, altered drug selection, and tailored surgical timing.
Pediatrics
Children younger than 2 years carry the highest incidence of acute otitis media (AOM) and derive the greatest benefit from antimicrobial therapy. In a meta-analysis of individual patient data, reduced persistent pain or fever at 3‑7 days by 25 percentage points (from 55% to 30%) for bilateral AOM in this age group, yielding a number needed to treat of 4 (NNT = 4) [121]A1a. The same analysis showed an NNT of 3 for children with otorrhoea [121]A1a. Diagnosis requires stringent otoscopic criteria, bulging, opacification, or impaired mobility, because clinical scoring alone overestimates disease [47]A1b. For children 6 to 23 months, ‑clavulanate for 10 days remains first‑line; a shortened 5‑day course resulted in significantly higher clinical failure (34% vs 16%, NNT = 6) [139]B2b. For recurrent AOM (≥3 episodes in 6 months or ≥4 in 12 months) in children 6 - 35 months, tympanostomy‑tube placement did not reduce the overall AOM rate over 2 years compared with medical (1.48 vs 1.56 episodes per child‑year, p = 0.66) [138]A1b. However, per‑protocol analysis favored tubes (1.47 vs 1.72), and secondary outcomes such as time to first episode and clinical findings were improved [138]A1b. Concurrent adenoidectomy at initial tube placement reduces the odds of repeat tube insertion (OR 0.46; 95% CI 0.39‑0.55), particularly in children older than 4 years [168]B2a. Pneumococcal conjugate vaccine (PCV) lowers the need for tympanostomy‑tube insertion (vaccine efficacy 22.2%; 95% CI 14.6‑29.8) and recurrent AOM (VE 10.1%) [134]A1a.
Pregnancy
Pregnancy alters AOM presentation because hormonally mediated mucosal edema of the Eustachian tube impedes middle‑ear ventilation. Treatment follows standard principles, but drug safety governs choice. Amoxicillin (FDA category B) and cephalosporins (category B) are first‑line. Tetracyclines (category D) and fluoroquinolones (category C in first trimester) should be avoided. For penicillin‑allergic patients, cefdinir is recommended [149]D5. Topical therapy for tympanostomy‑tube otorrhea, plus fluocinolone, is safe because systemic absorption is negligible [137]A1b. No evidence supports altered delivery planning for uncomplicated AOM.
Elderly
The elderly account for about 20% of AOM‑related emergency department visits and are more likely to present with complications (0.26% overall, but risk rises with age and comorbidity) [90]B2c. In a national database, patients with complicated AOM were older (mean 37 vs 10 years) and more often insured by Medicare (18% vs 2.1%) [90]B2c. Presentation may be subtle, hearing loss and vertigo may overshadow pain. and facial nerve palsy occur disproportionately in older adults [77]C4. Empiric antibiotics (amoxicillin‑clavulanate or a cephalosporin) should be dosed according to renal function. A low threshold for contrast‑enhanced CT or MRI is warranted when intracranial extension is suspected.
Immunocompromised
Immunocompromised hosts, including those with HIV, solid‑organ transplant, chemotherapy, or prolonged corticosteroid use, face a higher risk of severe disease, atypical pathogens, and suppurative complications. Empiric therapy should cover pseudomonal and anaerobic organisms; amoxicillin‑clavulanate or a third‑generation cephalosporin (e.g., 50 mg/kg daily) is appropriate. For children with cochlear implants, AOM during the first 2 months after implantation should be treated parenterally with ceftriaxone to mitigate meningitis risk; after 2 months, high‑dose amoxicillin‑clavulanate suffices [164]D5. Tympanocentesis for culture and low‑threshold tympanostomy‑tube drainage are recommended when response to initial therapy is poor. Vaccination against pneumococcus, type b, and influenza should be current [164]D5.
Pearl: In children <2 years with bilateral AOM, amoxicillin‑clavulanate for 10 days reduces treatment failure with NNT = 6; in pregnancy, amoxicillin and cephalosporins are safe; in the elderly and immunocompromised, a lower threshold for imaging and parenteral therapy is warranted because complications are more common and atypical pathogens may be involved.
Prevention, Screening and Surveillance
- ▸Pneumococcal conjugate vaccines reduce all-cause AOM by 6-7% in low-risk infants and have halved hospitalisations in young children since 2000 [223,225,237].
- ▸Primary prevention also includes influenza vaccination (maternal and childhood), COVID-19 vaccination, and modifiable risk factors; probiotics show no benefit [229].
- ▸Tympanostomy tubes are effective for secondary prevention of recurrent AOM but carry procedural risks; shared decision-making is essential [246].
Building on special population considerations, AOM prevention centres on vaccine-preventable pathogen reduction and risk factor modification.
Primary Prevention
Pneumococcal conjugate vaccines (PCVs) are the cornerstone. In low-risk infants, PCV7 reduced all-cause AOM by 6% to 7% (RRR 6%, 95% CI 4% to 9%) [223]A1a[225]A1a. Population-level impact: US paediatric AOM hospital admissions declined 34% from 2000 to 2012 [237]B2c; PCV13 lowered AOM incidence in infants <2 months from 1.2 to 0.45 per 1,000 live births in Israel [260]B2b. Serotypes 19A, 3, and NTHi persist [25]A1a[259]B2a. Influenza vaccination: maternal influenza vaccine reduced all-cause ALRI hospitalizations by 21% (95% CI 8% to 32%) in infants <6 months [257]A1a; live attenuated vaccine may reduce otitis media [6]A1a. vaccination in children prevented post-infection AOM in those aged 6-10 years (no significant risk) [249]B2b. (S. salivarius K12) showed no benefit (RR 1.42) [229]A1b. Modifiable factors: , smoke avoidance. In children with , plus antibiotic prophylaxis lowers meningitis risk (0.07% overall) [136]B2a. Children with chronic medical conditions have IRR 128.1 for IPD with ≥2 CMCs and should receive PCV per schedules [16]B2b.
Secondary Prevention
For recurrent AOM (≥3 episodes in 6 months or ≥4 in one year), reduce AOM recurrences at 3-6 months compared with active monitoring (Cochrane 2018) [246]A1a. Adenoidectomy is not routinely added. Shared decision-making balances benefit against risks of perforation and otorrhoea.
Screening and Surveillance
No universal AOM screening exists. An AI classifier using tympanic membrane images shows 92-100% sensitivity for abnormal ears, potentially ruling out AOM, but is not guideline-endorsed [110]A1b. Surveillance for recurrence and hearing loss is prudent in high-risk children.
Patient Education
Clinicians should emphasize PCV series completion, annual receipt, breastfeeding, smoke-free environments, and early ear-symptom evaluation. These measures substantially reduce AOM burden and antibiotic use [25]A1a.
Pearl: Complete PCV13 and annual influenza vaccination are the most effective population-level interventions; for recurrent AOM, tympanostomy tubes offer short-term reduction but require shared decision-making [246]A1a.
| Study | Population | Effect |
|---|---|---|
| CRM197-PCV7 [223]A1a[225]A1a | Low-risk infants | RRR 6-7% (95% CI 4-9%) |
| PCV13 (Israel) [260]B2b | Infants <2 months | Incidence reduced from 1.2 to 0.45 per 1000 live births |
| US hospital admissions [237]B2c | Children <21 years | 34% decline 2000-2012 |
References
- [1]
Tähtinen PA, Laine MK, Huovinen P et al.. “A placebo-controlled trial of antimicrobial treatment for acute otitis media.” The New England journal of medicine (2011). PMID: 21226577 ↗
L1RCTCited in: Definition, Classification and Anatomic Localization, Clinical Presentation, Acute and Emergency Management, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Prognosis and Natural History, Special Populations and Pregnancy - [2]
Castelli Gattinara G, Bergamini M, Simeone G et al.. “Antibiotic treatment of acute and recurrent otitis media in children: an Italian intersociety Consensus.” Italian journal of pediatrics (2025). PMID: 39980042 ↗
L1GUIDELINECited in: Definition, Classification and Anatomic Localization, History and Evolution of Treatment - [3]
Lu N, Kacin AJ, Shaffer AD et al.. “Otorhinologic Disorders in 22q11.2 Deletion Syndrome.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2023). PMID: 36950877 ↗
L4OTHERCited in: Definition, Classification and Anatomic Localization, Severity, Staging and Risk Stratification, Acute and Emergency Management, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Surgical Technique, Approaches and Perioperative Care, Prognosis and Natural History - [4]
Surapaneni S, Rangarajan N, Davis K et al.. “Toward an Unbiased Deep Learning Classifier of Pediatric Middle Ear Disease.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2025). PMID: 40955059 ↗
L2OTHERCited in: Definition, Classification and Anatomic Localization, Clinical Presentation, Severity, Staging and Risk Stratification - [5]
Crowson MG, Bates DW, Suresh K et al.. “"Human vs Machine" Validation of a Deep Learning Algorithm for Pediatric Middle Ear Infection Diagnosis.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2023). PMID: 35972815 ↗
L2OTHERCited in: Definition, Classification and Anatomic Localization, Severity, Staging and Risk Stratification - [6]
Jefferson T, Rivetti A, Di Pietrantonj C et al.. “Vaccines for preventing influenza in healthy children.” The Cochrane database of systematic reviews (2018). PMID: 29388195 ↗
L1SR_OBSCited in: Definition, Classification and Anatomic Localization, History and Evolution of Treatment, Prevention, Screening and Surveillance - [7]
Syed MI, Suller S, Browning GG et al.. “Interventions for the prevention of postoperative ear discharge after insertion of ventilation tubes (grommets) in children.” The Cochrane database of systematic reviews (2013). PMID: 23633358 ↗
L1SR_OBSCited in: Definition, Classification and Anatomic Localization - [8]
Hayashi T, Kitamura K, Hashimoto S et al.. “Clinical practice guidelines for the diagnosis and management of acute otitis media in children-2018 update.” Auris, nasus, larynx (2020). PMID: 32576390 ↗
L5GUIDELINECited in: Definition, Classification and Anatomic Localization, Severity, Staging and Risk Stratification - [9]
Dillen H, Wouters J, Snijders D et al.. “Factors associated with inappropriateness of antibiotic prescriptions for acutely ill children presenting to ambulatory care in high-income countries: a systematic review and meta-analysis.” The Journal of antimicrobial chemotherapy (2024). PMID: 38113395 ↗
L1SR_OBSCited in: Definition, Classification and Anatomic Localization - [10]
Shi J, Liu Y, Chen X et al.. “Effect of probiotic lozenges on improvement in tympanometric classification within 12 weeks in children aged 3-6 years with adenoid hypertrophy and otitis media with effusion undergoing non-surgical management: a randomized controlled trial.” Frontiers in cellular and infection microbiology (2026). PMID: 41737842 ↗
L1RCTCited in: Definition, Classification and Anatomic Localization, Severity, Staging and Risk Stratification, Acute and Emergency Management, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Complications, Prognosis and Natural History, Special Populations and Pregnancy - [11]
Wu Z, Lin Z, Li L et al.. “Deep Learning for Classification of Pediatric Otitis Media.” The Laryngoscope (2020). PMID: 33369754 ↗
L2OTHERCited in: Definition, Classification and Anatomic Localization, Diagnostic Imaging, Tissue Sampling and Workup, Severity, Staging and Risk Stratification, Acute and Emergency Management, Special Populations and Pregnancy - [12]
Belsky MA, Konanur A, Sim E et al.. “Advanced Practice Provider Clinics: Expediting Care For Children Undergoing Tympanostomy Tube Placement.” The Laryngoscope (2021). PMID: 33635578 ↗
L2OTHERCited in: Definition, Classification and Anatomic Localization, Clinical Presentation, Severity, Staging and Risk Stratification, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Surgical Technique, Approaches and Perioperative Care - [13]
Heward E, Dempsey J, McGovarin A et al.. “Defining the Terminology for Acute Ear Discharge in Children: Systematic Review and Expert Consensus Using the Nominal Group Technique.” Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery (2025). PMID: 40769763 ↗
L1SR_OBSCited in: Definition, Classification and Anatomic Localization - [14]
Habib AR, Kajbafzadeh M, Hasan Z et al.. “Artificial intelligence to classify ear disease from otoscopy: A systematic review and meta-analysis.” Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery (2022). PMID: 35253378 ↗
L1SR_OBSCited in: Definition, Classification and Anatomic Localization - [15]
Sáez-Llorens X, Rowley S, Wong D et al.. “Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trial.” Human vaccines & immunotherapeutics (2017). PMID: 28368738 ↗
L1RCTCited in: Definition, Classification and Anatomic Localization - [16]
Yano A, Imai K, Kim Y et al.. “Risk of developing pneumococcal disease in individuals under 19 years of age with chronic medical conditions: a retrospective cohort study using a Japanese insurance claims database.” BMJ open (2026). PMID: 41577349 ↗
L2COHORTCited in: Definition, Classification and Anatomic Localization, Severity, Staging and Risk Stratification, Prevention, Screening and Surveillance - [17]
Tran TT, Fang TY, Pham VT et al.. “Development of an Automatic Diagnostic Algorithm for Pediatric Otitis Media.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2018). PMID: 30015751 ↗
L4OTHERCited in: Definition, Classification and Anatomic Localization, Severity, Staging and Risk Stratification - [18]
Habib AR, Crossland G, Patel H et al.. “An Artificial Intelligence Computer-vision Algorithm to Triage Otoscopic Images From Australian Aboriginal and Torres Strait Islander Children.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2022). PMID: 35239622 ↗
L2OTHERCited in: Definition, Classification and Anatomic Localization, Severity, Staging and Risk Stratification - [19]
Tsutsumi K, Goshtasbi K, Risbud A et al.. “A Web-Based Deep Learning Model for Automated Diagnosis of Otoscopic Images.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2021). PMID: 34191783 ↗
L4OTHERCited in: Definition, Classification and Anatomic Localization, Severity, Staging and Risk Stratification, Acute and Emergency Management - [20]
Tobe Y, Yamazaki H, Shirakawa C et al.. “Management of Already Inserted Ventilation Tubes During Pediatric Cochlear Implantation: To Remove or Leave the Tube?” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2023). PMID: 36728465 ↗
L2OTHERCited in: Definition, Classification and Anatomic Localization, Surgical Technique, Approaches and Perioperative Care, Complications - [21]
Chung J, Lee DY, Kim YH. “Management of myringitis: Current concepts and review.” The Laryngoscope (2018). PMID: 29573362 ↗
L1SR_OBSCited in: Pathophysiology and Mechanism, Acute and Emergency Management, Medical versus Surgical Management (Definitive), Surgical Technique, Approaches and Perioperative Care, Prognosis and Natural History, Special Populations and Pregnancy - [22]
Pelton SI, Pettigrew MM, Barenkamp SJ et al.. “Panel 6: Vaccines.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2013). PMID: 23536534 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology and Mechanism, Acute and Emergency Management, Medical versus Surgical Management (Definitive), Prognosis and Natural History - [23]
Antonelli PJ, Schultz GS, Sundin DJ et al.. “Alpha1-antitrypsin single dose adjuvant therapy for acute otitis media.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2006). PMID: 16815194 ↗
L5OTHERCited in: Pathophysiology and Mechanism, Audiologic, Vestibular and Endoscopic Assessment, Medical versus Surgical Management (Definitive) - [24]
Hamilton-Smith R, Ferdous S, Trusinska D et al.. “RSV-associated acute otitis media in children under five years old: a systematic review and meta-analysis.” Journal of global health (2026). PMID: 42359822 ↗
L1SR_OBSCited in: Pathophysiology and Mechanism, Acute and Emergency Management, Complications, Special Populations and Pregnancy - [25]
Bhuiyan MU, Hernandez-Suarez G, Pilishvili T et al.. “Incidence and bacterial etiology of acute otitis media in children in the pneumococcal conjugate vaccine era: A systematic literature review and meta-analysis.” Vaccine (2026). PMID: 41616651 ↗
L1SR_OBSCited in: Pathophysiology and Mechanism, Acute and Emergency Management, Special Populations and Pregnancy, Prevention, Screening and Surveillance - [26]
Keskin Yilmaz N, Shimura T, Koerig Schuster A et al.. “Relationship Between Cochlear Lateral Wall Changes and Endolymphatic Hydrops in Otitis Media.” The Laryngoscope (2024). PMID: 38958129 ↗
L4OTHERCited in: Pathophysiology and Mechanism, Acute and Emergency Management - [27]
Chai Y, He W, Yang W et al.. “Intratympanic Lipopolysaccharide Elevates Systemic Fluorescent Gentamicin Uptake in the Cochlea.” The Laryngoscope (2021). PMID: 33956344 ↗
L5OTHERCited in: Pathophysiology and Mechanism, Acute and Emergency Management, Medical versus Surgical Management (Definitive), Special Populations and Pregnancy - [28]
Choi JW, Han K, Nahm H et al.. “Direction-Changing Positional Nystagmus in Acute Otitis Media Complicated by Serous Labyrinthitis: New Insights into Positional Nystagmus.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2019). PMID: 30870366 ↗
L4CASE_REPORTCited in: Pathophysiology and Mechanism, Audiologic, Vestibular and Endoscopic Assessment, Diagnostic Imaging, Tissue Sampling and Workup - [29]
Karmody CS, Northrop C. “The pathogenesis of acquired cholesteatoma of the human middle ear: support for the migration hypothesis.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2012). PMID: 22143292 ↗
L4CASE_REPORTCited in: Pathophysiology and Mechanism, Medical versus Surgical Management (Definitive) - [30]
Zielnik-Jurkiewicz B, Stankiewicz-Szymczak W. “Pro-inflammatory interleukins in middle ear effusions from atopic and non-atopic children with chronic otitis media with effusion.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2015). PMID: 26078091 ↗
L3OTHERCited in: Pathophysiology and Mechanism, Clinical Presentation - [31]
Taha A, Pitaro J, Lazarovitch T et al.. “The association between Helicobacter pylori and chronic otitis media with effusion.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2022). PMID: 36178529 ↗
L3OTHERCited in: Pathophysiology and Mechanism, Acute and Emergency Management, Surgical Technique, Approaches and Perioperative Care, Special Populations and Pregnancy - [32]
Švagan M, Rebol J. “Long-term outcomes of surgical treatment for paediatric acute mastoiditis: the role of mastoidectomy.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2024). PMID: 39616553 ↗
L4OTHERCited in: Pathophysiology and Mechanism, Audiologic, Vestibular and Endoscopic Assessment, Medical versus Surgical Management (Definitive), Prognosis and Natural History - [33]
Salomonsen RL, Hermansson A, Cayé-Thomasen P. “Ossicular bone modeling in acute otitis media.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2010). PMID: 20657333 ↗
L5OTHERCited in: Pathophysiology and Mechanism, Acute and Emergency Management - [34]
de Miguel Martinez I, Macias AR. “Serous otitis media in children: implication of Alloiococcus otitidis.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2008). PMID: 18418283 ↗
L2OTHERCited in: Pathophysiology and Mechanism - [35]
de Carvalho Leal M, Ferreira Bento R, da Silva Caldas Neto S et al.. “Influence of hypercalcemia in the formation of tympanosclerosis in rats.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2006). PMID: 16371843 ↗
L5OTHERCited in: Pathophysiology and Mechanism, Diagnostic Imaging, Tissue Sampling and Workup - [36]
Zahid A, Wilson JC, Grice ID et al.. “Otitis media: recent advances in otitis media vaccine development and model systems.” Frontiers in microbiology (2024). PMID: 38328427 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology and Mechanism - [37]
Kotowski M, Szydlowski J. “Otogenic Cerebral Sinus Thrombosis in Children: A Narrative Review.” Neurology and therapy (2023). PMID: 37266793 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology and Mechanism - [38]
Mohammadi M. “HBoV-1: virus structure, genomic features, life cycle, pathogenesis, epidemiology, diagnosis and clinical manifestations.” Frontiers in cellular and infection microbiology (2023). PMID: 37265497 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology and Mechanism - [39]
Dhingra S, Vir D, Bakshi J et al.. “Mapping of audiometric analysis with microbiological findings in patients with chronic suppurative otitis media (CSOM): a neglected clinical manifestation.” Critical reviews in clinical laboratory sciences (2023). PMID: 36604829 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology and Mechanism - [40]
You MW, Kim D, Lee EH et al.. “The Roles of NOD-like Receptors in Innate Immunity in Otitis Media.” International journal of molecular sciences (2022). PMID: 35216465 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology and Mechanism - [41]
Jung SY, Kim D, Park DC et al.. “Toll-Like Receptors: Expression and Roles in Otitis Media.” International journal of molecular sciences (2021). PMID: 34360632 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology and Mechanism - [42]
Folino F, Ruggiero L, Capaccio P et al.. “Upper Respiratory Tract Microbiome and Otitis Media Intertalk: Lessons from the Literature.” Journal of clinical medicine (2020). PMID: 32887458 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology and Mechanism - [43]
Rosenfeld RM, Schwartz SR, Pynnonen MA et al.. “Clinical practice guideline: Tympanostomy tubes in children.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2013). PMID: 23818543 ↗
L1GUIDELINECited in: Clinical Presentation, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Surgical Technique, Approaches and Perioperative Care, Prognosis and Natural History, Special Populations and Pregnancy - [44]
Harvey M, Bowe SN, Laury AM. “Clinical Practice Guidelines: Whose Practice Are We Guiding?” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2016). PMID: 27329423 ↗
L4GUIDELINECited in: Clinical Presentation, Acute and Emergency Management, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Special Populations and Pregnancy - [45]
Hellström S, Groth A, Jörgensen F et al.. “Ventilation tube treatment: a systematic review of the literature.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2011). PMID: 21632976 ↗
L2SR_OBSCited in: Clinical Presentation, Severity, Staging and Risk Stratification, Acute and Emergency Management, Medical versus Surgical Management (Definitive), Surgical Technique, Approaches and Perioperative Care, Prognosis and Natural History, Special Populations and Pregnancy - [46]
Stepniak C, Wickens B, Husein M et al.. “Blinded randomized controlled study of a web-based otoscopy simulator in undergraduate medical education.” The Laryngoscope (2016). PMID: 27577536 ↗
L1RCTCited in: Clinical Presentation, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Surgical Technique, Approaches and Perioperative Care - [47]
Hoberman A, Paradise JL, Rockette HE et al.. “Treatment of acute otitis media in children under 2 years of age.” The New England journal of medicine (2011). PMID: 21226576 ↗
L1RCTCited in: Clinical Presentation, Acute and Emergency Management, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Prognosis and Natural History, Special Populations and Pregnancy - [48]
Talmor G, Vakil M, Tseng C et al.. “Petrous Apicitis: A Systematic Review and Case Presentation.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2022). PMID: 35878630 ↗
L4SR_OBSCited in: Clinical Presentation, Diagnostic Imaging, Tissue Sampling and Workup, Acute and Emergency Management, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Surgical Technique, Approaches and Perioperative Care, Complications - [49]
Aarhus L, Tambs K, Hoffman HJ et al.. “Childhood otitis media is associated with dizziness in adulthood: the HUNT cohort study.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2015). PMID: 26335289 ↗
L2COHORTCited in: Clinical Presentation, Audiologic, Vestibular and Endoscopic Assessment, History and Evolution of Treatment - [50]
van de Heyning P, Muehlmeier G, Cox T et al.. “Efficacy and safety of AM-101 in the treatment of acute inner ear tinnitus--a double-blind, randomized, placebo-controlled phase II study.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2014). PMID: 24603353 ↗
L1RCTCited in: Clinical Presentation, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Prognosis and Natural History - [51]
Ho AC, Chan JY, Ng RW et al.. “The role of myringotomy and ventilation tube insertion in maxillary swing approach nasopharyngectomy: review of our 10-year experience.” The Laryngoscope (2012). PMID: 22951935 ↗
L4REVIEW_NARRATIVECited in: Clinical Presentation, Medical versus Surgical Management (Definitive) - [52]
Luu K, Park J, Shaffer AD et al.. “Long-Term Otitis Media Outcomes in Infants With Early Tympanostomy Tubes.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2020). PMID: 32539603 ↗
L4OTHERCited in: Clinical Presentation - [53]
Preciado D, Nolan RM, Joshi R et al.. “Otitis Media Middle Ear Effusion Identification and Characterization Using an Optical Coherence Tomography Otoscope.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2020). PMID: 31959053 ↗
L4OTHERCited in: Clinical Presentation, Diagnostic Imaging, Tissue Sampling and Workup - [54]
Gutierrez C, Nazar GA, Torres JP. “Otolaryngological complications in patients infected with the influenza A (H1N1) virus.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2011). PMID: 21998086 ↗
L4OTHERCited in: Clinical Presentation, Severity, Staging and Risk Stratification - [55]
Venekamp RP, Sanders SL, Glasziou PP et al.. “Antibiotics for acute otitis media in children.” The Cochrane database of systematic reviews (2023). PMID: 37965923 ↗
L1SR_OBSCited in: Clinical Presentation, Audiologic, Vestibular and Endoscopic Assessment, Acute and Emergency Management, Surgical Technique, Approaches and Perioperative Care, Complications, Special Populations and Pregnancy - [56]
Spinks A, Glasziou PP, Del Mar CB. “Antibiotics for treatment of sore throat in children and adults.” The Cochrane database of systematic reviews (2021). PMID: 34881426 ↗
L1SR_OBSCited in: Clinical Presentation, Acute and Emergency Management, Surgical Technique, Approaches and Perioperative Care, Special Populations and Pregnancy - [57]
Spurling GK, Dooley L, Clark J et al.. “Immediate versus delayed versus no antibiotics for respiratory infections.” The Cochrane database of systematic reviews (2023). PMID: 37791590 ↗
L1SR_OBSCited in: Clinical Presentation, Acute and Emergency Management, Surgical Technique, Approaches and Perioperative Care, Complications, Special Populations and Pregnancy - [58]
de Sévaux JLH, Damoiseaux RA, van de Pol AC et al.. “Paracetamol (acetaminophen) or non-steroidal anti-inflammatory drugs, alone or combined, for pain relief in acute otitis media in children.” The Cochrane database of systematic reviews (2023). PMID: 37594020 ↗
L1SR_OBSCited in: Clinical Presentation, Acute and Emergency Management, Special Populations and Pregnancy - [59]
Mulvaney CA, Galbraith K, Webster KE et al.. “Antibiotics for otitis media with effusion (OME) in children.” The Cochrane database of systematic reviews (2023). PMID: 37870130 ↗
L1SR_OBSCited in: Clinical Presentation, Acute and Emergency Management, Complications, Special Populations and Pregnancy - [60]
Foxlee R, Johansson A, Wejfalk J et al.. “Topical analgesia for acute otitis media.” The Cochrane database of systematic reviews (2006). PMID: 16856108 ↗
L1SR_OBSCited in: Clinical Presentation, Acute and Emergency Management - [61]
Spurling GK, Del Mar CB, Dooley L et al.. “Delayed antibiotics for respiratory infections.” The Cochrane database of systematic reviews (2013). PMID: 23633320 ↗
L1SR_OBSCited in: Clinical Presentation, Medical versus Surgical Management (Definitive), Surgical Technique, Approaches and Perioperative Care, Complications - [62]
Venekamp RP, Sanders SL, Glasziou PP et al.. “Antibiotics for acute otitis media in children.” The Cochrane database of systematic reviews (2015). PMID: 26099233 ↗
L1SR_OBSCited in: Clinical Presentation, Audiologic, Vestibular and Endoscopic Assessment, Surgical Technique, Approaches and Perioperative Care, Prognosis and Natural History - [63]
Venekamp RP, Sanders S, Glasziou PP et al.. “Antibiotics for acute otitis media in children.” The Cochrane database of systematic reviews (2013). PMID: 23440776 ↗
L1SR_OBSCited in: Clinical Presentation, Audiologic, Vestibular and Endoscopic Assessment, Surgical Technique, Approaches and Perioperative Care, Prognosis and Natural History - [64]
le Clercq CMP, van Ingen G, Ruytjens L et al.. “Prevalence of Hearing Loss Among Children 9 to 11 Years Old: The Generation R Study.” JAMA otolaryngology-- head & neck surgery (2017). PMID: 28750130 ↗
L4OTHERCited in: Clinical Presentation, Audiologic, Vestibular and Endoscopic Assessment, Acute and Emergency Management, History and Evolution of Treatment, Special Populations and Pregnancy - [65]
Aarhus L, Engdahl B, Tambs K et al.. “Association Between Childhood Hearing Disorders and Tinnitus in Adulthood.” JAMA otolaryngology-- head & neck surgery (2015). PMID: 26540147 ↗
L2OTHERCited in: Clinical Presentation, Audiologic, Vestibular and Endoscopic Assessment, Acute and Emergency Management, History and Evolution of Treatment, Special Populations and Pregnancy - [66]
Dinleyici EC, Ozen M, Guven S et al.. “Effect of Limosilactobacillus reuteri DSM17938 to prevent antibiotic-associated diarrhea in children: prospective, multi-center, randomized, placebo-controlled clinical trial (PEARL Study).” European journal of pediatrics (2025). PMID: 40488914 ↗
L1RCTCited in: Clinical Presentation, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Surgical Technique, Approaches and Perioperative Care, Prognosis and Natural History - [67]
Liu HF, Wang YY, Zhang XZ et al.. “Comparison of characteristics of children hospitalized for respiratory syncytial virus infection during the pre- and post-COVID-19 eras: a multicenter retrospective study.” BMC infectious diseases (2024). PMID: 39300365 ↗
L2COHORTCited in: Clinical Presentation - [68]
Bjar N, Hermansson A, Gisselsson-Solen M. “How common is otogenic meningitis? A retrospective study in southern Sweden over 18 years.” Infection (2024). PMID: 38416397 ↗
L4COHORTCited in: Clinical Presentation - [69]
Abukmail E, Bakhit M, Jones M et al.. “Effect of different visual presentations on the public's comprehension of prognostic information using acute and chronic condition scenarios: two online randomised controlled trials.” BMJ open (2023). PMID: 37316324 ↗
L1RCTCited in: Clinical Presentation, Prognosis and Natural History - [70]
Sayal NR, Boyd S, Zach White G et al.. “Incidental mastoid effusion diagnosed on imaging: Are we doing right by our patients?” The Laryngoscope (2018). PMID: 30570749 ↗
L4OTHERCited in: Clinical Presentation, Diagnostic Imaging, Tissue Sampling and Workup - [71]
Ghaheri BA, Kempton JB, Pillers DA et al.. “Cochlear cytokine gene expression in murine acute otitis media.” The Laryngoscope (2007). PMID: 17202925 ↗
L5OTHERCited in: Clinical Presentation, Acute and Emergency Management - [72]
Cordeiro FP, da Costa Monsanto R, Kasemodel ALP et al.. “Extended high-frequency hearing loss following the first episode of otitis media.” The Laryngoscope (2018). PMID: 30194735 ↗
L2OTHERCited in: Clinical Presentation, Audiologic, Vestibular and Endoscopic Assessment, Acute and Emergency Management, Complications, Prognosis and Natural History - [73]
Neuberger R, Carter J, Dives A et al.. “Optical Coherence Tomography as an Emerging Technique for Identifying Pediatric Middle Ear Effusion.” The Laryngoscope (2025). PMID: 41342403 ↗
L4OTHERCited in: Clinical Presentation, Audiologic, Vestibular and Endoscopic Assessment, Diagnostic Imaging, Tissue Sampling and Workup - [74]
Sidell D, Shapiro NL, Bhattacharyya N. “Obesity and the risk of chronic rhinosinusitis, allergic rhinitis, and acute otitis media in school-age children.” The Laryngoscope (2013). PMID: 23918707 ↗
L4OTHERCited in: Clinical Presentation - [75]
Mey KH, Sørensen MS, Homøe P. “Histomorphometric estimation of air cell development in experimental otitis media.” The Laryngoscope (2006). PMID: 17003720 ↗
L5OTHERCited in: Clinical Presentation - [76]
Mosquera FEC, de la Rosa Caldas M, Naranjo Rojas A et al.. “Probiotic, Prebiotic, and Synbiotic Supplementation for the Prevention and Treatment of Acute Otitis Media: A Systematic Review and Meta-Analysis.” Children (Basel, Switzerland) (2025). PMID: 40426770 ↗
L1SR_OBSCited in: Clinical Presentation - [77]
Makeham TP, Croxson GR, Coulson S. “Infective causes of facial nerve paralysis.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2007). PMID: 17031324 ↗
L4CASE_REPORTCited in: Clinical Presentation, Severity, Staging and Risk Stratification, Acute and Emergency Management, Medical versus Surgical Management (Definitive), Surgical Technique, Approaches and Perioperative Care, Special Populations and Pregnancy - [78]
James AL, Papsin BC. “Endoscopic Repair of Round Window Cochleocele.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2022). PMID: 36156534 ↗
L4CASE_REPORTCited in: Clinical Presentation, Diagnostic Imaging, Tissue Sampling and Workup, Acute and Emergency Management, Medical versus Surgical Management (Definitive), Surgical Technique, Approaches and Perioperative Care, Complications, Special Populations and Pregnancy - [79]
Weiss I, Marom T, Goldfarb A et al.. “Luc's abscess: the return of an old fellow.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2010). PMID: 20502372 ↗
L4CASE_REPORTCited in: Clinical Presentation, Diagnostic Imaging, Tissue Sampling and Workup, Medical versus Surgical Management (Definitive), Surgical Technique, Approaches and Perioperative Care, Complications - [80]
Michel F. “Progressively Recovering Auditory Brainstem Response in a Cochlear-implanted Child After Meningitis: A Case Report.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2016). PMID: 26485596 ↗
L4CASE_REPORTCited in: Clinical Presentation - [81]
Matsuda H, Sawada M, Suzuki K et al.. “Efficacy of 1.5% levofloxacin otic solution in treating acute otitis externa: A post hoc analysis of ENT103-3001, a multicenter randomized double-blind parallel-group placebo-controlled phase III study in otitis media with persistent otorrhea.” Auris, nasus, larynx (2024). PMID: 39476787 ↗
L2RCTCited in: Clinical Presentation, Medical versus Surgical Management (Definitive) - [82]
Venditto L, Ferrante G, Caccin A et al.. “Lung abscess as a complication of Lemierre Syndrome in adolescents: a single center case reports and review of the literature.” Italian journal of pediatrics (2023). PMID: 37563612 ↗
L4CASE_REPORTCited in: Clinical Presentation - [83]
Rosso C, Colletti L, Foltran M et al.. “Effects of rapid maxillary expansion on hearing loss and otitis media in cleft palate children.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2021). PMID: 34854972 ↗
L2OTHERCited in: Clinical Presentation, Audiologic, Vestibular and Endoscopic Assessment, Acute and Emergency Management, Surgical Technique, Approaches and Perioperative Care, Special Populations and Pregnancy - [84]
Park JH, Park SJ, Kim YH et al.. “Sensorineural hearing loss: a complication of acute otitis media in adults.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2013). PMID: 23990061 ↗
L4OTHERCited in: Clinical Presentation, Audiologic, Vestibular and Endoscopic Assessment, Acute and Emergency Management - [85]
Zloczower E, Bartov N, Allon R et al.. “The impact of birth weight and gestational age on acute mastoiditis in children.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2022). PMID: 36153783 ↗
L2OTHERCited in: Clinical Presentation, Surgical Technique, Approaches and Perioperative Care, Prognosis and Natural History - [86]
Li G, Li T, Liu H et al.. “Correlation between recovery time of extended high-frequency audiometry and duration of inflammation in patients with acute otitis media.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2020). PMID: 32333137 ↗
L4OTHERCited in: Clinical Presentation, Audiologic, Vestibular and Endoscopic Assessment - [87]
Thielker J, Heuschkel A, Boeger D et al.. “Patients with non-idiopathic sudden sensorineural hearing loss show hearing improvement more often than patients with idiopathic sudden sensorineural hearing loss.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2021). PMID: 33683448 ↗
L2OTHERCited in: Clinical Presentation, Medical versus Surgical Management (Definitive), Prognosis and Natural History - [88]
Sokolov M, Tzelnick S, Stern S et al.. “Acute mastoiditis in infants younger than 6 months: is an alternative treatment protocol needed?” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2020). PMID: 32500325 ↗
L2OTHERCited in: Clinical Presentation - [89]
Marom T, Schwarz Y, Gluck O et al.. “Trends in Pediatric Acute Otitis Media Burden During the First COVID-19 Year.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2022). PMID: 35878638 ↗
L2OTHERCited in: Clinical Presentation, Acute and Emergency Management, Special Populations and Pregnancy - [90]
Ren Y, Sethi RKV, Stankovic KM. “Acute Otitis Media and Associated Complications in United States Emergency Departments.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2018). PMID: 30113560 ↗
L2OTHERCited in: Clinical Presentation, Acute and Emergency Management, Surgical Technique, Approaches and Perioperative Care, Complications, Special Populations and Pregnancy - [91]
Kasuga M, Yoshimura H, Takumi Y. “Temporal Swelling Following Cochlear Implantation: Frequency, Treatment, and Outcomes.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2024). PMID: 38573599 ↗
L2OTHERCited in: Clinical Presentation, Diagnostic Imaging, Tissue Sampling and Workup, Acute and Emergency Management, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Surgical Technique, Approaches and Perioperative Care, Complications, Prognosis and Natural History, Special Populations and Pregnancy - [92]
Kerschner JE, Daley RA, Link R et al.. “Clinical trial assessing the use of optical coherence tomography in decision making for children presenting with acute otitis media.” International journal of pediatric otorhinolaryngology (2026). PMID: 41547297 ↗
L2TRIAL_NONRANDOMCited in: Clinical Presentation, Diagnostic Imaging, Tissue Sampling and Workup - [93]
Noda M, Akiyoshi R, Hosoya M et al.. “Telehealth Approaches for Pediatric Otitis Media and Clinical Outcomes: Scoping Review.” Journal of medical Internet research (2026). PMID: 41850731 ↗
L5REVIEW_NARRATIVECited in: Clinical Presentation - [94]
Zayan K, Shaffer A, Rushchak M et al.. “Randomized clinical trial of post-operative outcomes following posterior versus anterior tympanostomy tube placement: preliminary results at 2-12 week follow-up.” International journal of pediatric otorhinolaryngology (2025). PMID: 41475335 ↗
L1RCTCited in: Audiologic, Vestibular and Endoscopic Assessment, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Surgical Technique, Approaches and Perioperative Care - [95]
Takahashi M, Iwasaki S, Kawano T et al.. “Efficacy and safety of 1.5% levofloxacin otic solution for the treatment of otitis media in a multicenter, randomized, double-blind, parallel-group, placebo-controlled, phase III study.” Auris, nasus, larynx (2023). PMID: 36599786 ↗
L1RCTCited in: Audiologic, Vestibular and Endoscopic Assessment - [96]
Leach AJ, Mulholland EK, Santosham M et al.. “Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial.” BMC pediatrics (2021). PMID: 33685411 ↗
L1RCTCited in: Audiologic, Vestibular and Endoscopic Assessment - [97]
Holm NH, Rusan M, Ovesen T. “Acute otitis media and antibiotics - a systematic review.” Danish medical journal (2020). PMID: 33215607 ↗
L1SR_OBSCited in: Audiologic, Vestibular and Endoscopic Assessment - [98]
Grueninger I, van de Loo J, Alekuzei S et al.. “Disease-specificity in correlations between speech audiometry, hearing-related quality of life, and varying calculation methods for pure tone average in middle ear diseases.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2026). PMID: 42223617 ↗
L2OTHERCited in: Audiologic, Vestibular and Endoscopic Assessment - [99]
Leichtle A, Hollfelder D, Wollenberg B et al.. “Balloon Eustachian Tuboplasty in children.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2017). PMID: 28283791 ↗
L4OTHERCited in: Audiologic, Vestibular and Endoscopic Assessment, Acute and Emergency Management, Medical versus Surgical Management (Definitive), Surgical Technique, Approaches and Perioperative Care, Prognosis and Natural History, Special Populations and Pregnancy - [100]
Zhang J, Zhong Z, Xiao S et al.. “Tubomanometry value as an associated factor for medication outcomes in adult acute otitis media with effusion.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2017). PMID: 29075980 ↗
L2OTHERCited in: Audiologic, Vestibular and Endoscopic Assessment, Diagnostic Imaging, Tissue Sampling and Workup, Medical versus Surgical Management (Definitive), Prognosis and Natural History - [101]
Tisch M, Maier S, Preyer S et al.. “Balloon Eustachian Tuboplasty (BET) in Children: A Retrospective Multicenter Analysis.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2020). PMID: 32658110 ↗
L4OTHERCited in: Audiologic, Vestibular and Endoscopic Assessment - [102]
Persson F, Bjar N, Hermansson A et al.. “Hearing loss after bacterial meningitis, a retrospective study.” Acta oto-laryngologica (2022). PMID: 35404758 ↗
L3COHORTCited in: Audiologic, Vestibular and Endoscopic Assessment - [103]
Rahmati MB, Safdarian F, Shiroui B et al.. “Montelukast versus inhaled mometasone for treatment of otitis media with effusion in children: A randomized controlled trial.” Electronic physician (2017). PMID: 28894551 ↗
L1RCTCited in: Audiologic, Vestibular and Endoscopic Assessment - [104]
Hughes A, Danehy A, Adil E. “Case 226: Oval Window Atresia.” Radiology (2016). PMID: 26789605 ↗
L4CASE_REPORTCited in: Audiologic, Vestibular and Endoscopic Assessment - [105]
Torretta S, Marchisio P, Drago L et al.. “Nasopharyngeal biofilm-producing otopathogens in children with nonsevere recurrent acute otitis media.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2012). PMID: 22357644 ↗
L3OTHERCited in: Diagnostic Imaging, Tissue Sampling and Workup - [106]
Higgins TS, McCabe SJ, Bumpous JM et al.. “Medical decision analysis: indications for tympanostomy tubes in RAOM by age at first episode.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2008). PMID: 18164993 ↗
L5OTHERCited in: Diagnostic Imaging, Tissue Sampling and Workup - [107]
Huang Y, Liang L, Zhang L et al.. “Eustachian Tube Characteristics in Patients With Turner Syndrome: A CT-Based Radiological Analysis.” The Laryngoscope (2025). PMID: 39976358 ↗
L3OTHERCited in: Diagnostic Imaging, Tissue Sampling and Workup - [108]
Fernandez IJ, Crocetta FM, Pelligra I et al.. “Clinical features and management of Luc's abscess: Case report and systematic review of the literature.” Auris, nasus, larynx (2019). PMID: 31812444 ↗
L4SR_OBSCited in: Diagnostic Imaging, Tissue Sampling and Workup - [109]
Redaelli de Zinis LO, Gasparotti R, Campovecchi C et al.. “Internal jugular vein thrombosis associated with acute mastoiditis in a pediatric age.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2006). PMID: 17006344 ↗
L5CASE_REPORTCited in: Diagnostic Imaging, Tissue Sampling and Workup, Medical versus Surgical Management (Definitive) - [110]
Nuuttila S, Vallin A, Klockars T et al.. “An artificial intelligence classifier as a screening tool to rule out otitis media in children.” International journal of pediatric otorhinolaryngology (2026). PMID: 42114455 ↗
L1RCTCited in: Diagnostic Imaging, Tissue Sampling and Workup, Acute and Emergency Management, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Prevention, Screening and Surveillance - [111]
Polat S, Aksoy E, Serin GM et al.. “Incidental diagnosis of mastoiditis on MRI.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2011). PMID: 21298388 ↗
L4OTHERCited in: Diagnostic Imaging, Tissue Sampling and Workup - [112]
Stern Shavit S, Raveh E, Levi L et al.. “Surgical intervention for acute mastoiditis: 10 years experience in a tertiary children hospital.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2019). PMID: 31456037 ↗
L3OTHERCited in: Diagnostic Imaging, Tissue Sampling and Workup, Medical versus Surgical Management (Definitive), Complications - [113]
Draut S, Müller J, Hempel JM et al.. “Tenfold Increase: Acute Pediatric Mastoiditis Before, During, and After COVID-19 Restrictions.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2024). PMID: 38956778 ↗
L2OTHERCited in: Diagnostic Imaging, Tissue Sampling and Workup, Surgical Technique, Approaches and Perioperative Care, Special Populations and Pregnancy - [114]
Ni T, Zhao F. “Predicting myocardial damage in children with mycoplasma pneumoniae pneumonia: a retrospective case-control study.” BMC infectious diseases (2025). PMID: 40405087 ↗
L3CASE_CONTROLCited in: Diagnostic Imaging, Tissue Sampling and Workup - [115]
Guida M, Farruggia P, Pellegrino C et al.. “Bilateral acute mastoiditis during Epstein-Barr virus infection in a child with alagille syndrome: a case report and scoping review.” Italian journal of pediatrics (2026). PMID: 42260672 ↗
L4CASE_REPORTCited in: Diagnostic Imaging, Tissue Sampling and Workup - [116]
Hashimoto K, Yamamoto H, Isogai J et al.. “Biopsy-proven acute eosinophilic myocarditis as the initial manifestation of severe primary Sjögren's syndrome: a case report.” Frontiers in cardiovascular medicine (2025). PMID: 41132250 ↗
L4CASE_REPORTCited in: Diagnostic Imaging, Tissue Sampling and Workup - [117]
Castellazzi ML, di Pietro GM, Gaffuri M et al.. “Pediatric otogenic cerebral venous sinus thrombosis: a case report and a literature review.” Italian journal of pediatrics (2020). PMID: 32883359 ↗
L4CASE_REPORTCited in: Diagnostic Imaging, Tissue Sampling and Workup - [118]
Mancini AJ, Glassman RD, Chang YM et al.. “Headache in Petrous Apicitis: A Case Report of Chronic Migraine-like Headache Due to Peripheral Pathology.” Headache (2019). PMID: 31535370 ↗
L4CASE_REPORTCited in: Diagnostic Imaging, Tissue Sampling and Workup - [119]
Sturm JJ, Huyett P, Shaffer A et al.. “Quality Assessment of the Clinical Practice Guideline for Tympanostomy Tubes in Children.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2018). PMID: 30060718 ↗
L4GUIDELINECited in: Severity, Staging and Risk Stratification, Medical versus Surgical Management (Definitive), Prognosis and Natural History - [120]
Mikals SJ, Brigger MT. “Adenoidectomy as an adjuvant to primary tympanostomy tube placement: a systematic review and meta-analysis.” JAMA otolaryngology-- head & neck surgery (2014). PMID: 24287958 ↗
L1SR_OBSCited in: Severity, Staging and Risk Stratification, Acute and Emergency Management, Medical versus Surgical Management (Definitive), Surgical Technique, Approaches and Perioperative Care, Complications, Prognosis and Natural History, Special Populations and Pregnancy - [121]
Rovers MM, Glasziou P, Appelman CL et al.. “Antibiotics for acute otitis media: a meta-analysis with individual patient data.” Lancet (London, England) (2006). PMID: 17055944 ↗
L1SR_OBSCited in: Severity, Staging and Risk Stratification, Acute and Emergency Management, Special Populations and Pregnancy - [122]
Marchisio P, Bortone B, Ciarcià M et al.. “Updated Guidelines for the Management of Acute Otitis Media in Children by the Italian Society of Pediatrics: Prevention.” The Pediatric infectious disease journal (2019). PMID: 31876602 ↗
L1GUIDELINECited in: Severity, Staging and Risk Stratification - [123]
Chiappini E, Ciarcià M, Bortone B et al.. “Updated Guidelines for the Management of Acute Otitis Media in Children by the Italian Society of Pediatrics: Diagnosis.” The Pediatric infectious disease journal (2019). PMID: 31876600 ↗
L1GUIDELINECited in: Severity, Staging and Risk Stratification - [124]
Grindler DJ, Blank SJ, Schulz KA et al.. “Impact of Otitis Media Severity on Children's Quality of Life.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2014). PMID: 24627408 ↗
L2OTHERCited in: Severity, Staging and Risk Stratification, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Prognosis and Natural History - [125]
Sibbald AD. “Acute otitis media in infants: the disease and the illness. Clinical distinctions for the new treatment paradigm.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2012). PMID: 22864406 ↗
L5REVIEW_NARRATIVECited in: Severity, Staging and Risk Stratification, Surgical Technique, Approaches and Perioperative Care - [126]
Heidemann CH, Lous J, Berg J et al.. “Danish guidelines on management of otitis media in preschool children.” International journal of pediatric otorhinolaryngology (2016). PMID: 27368465 ↗
L1GUIDELINECited in: Severity, Staging and Risk Stratification - [127]
Kitamura K, Iino Y, Kamide Y et al.. “Clinical practice guidelines for the diagnosis and management of acute otitis media (AOM) in children in Japan - 2013 update.” Auris, nasus, larynx (2014). PMID: 25450605 ↗
L1GUIDELINECited in: Severity, Staging and Risk Stratification - [128]
Kleinman K, Psoter KJ, Nyhan A et al.. “Evaluation of digital otoscopy in pediatric patients: A prospective randomized controlled clinical trial.” The American journal of emergency medicine (2021). PMID: 33945977 ↗
L1RCTCited in: Severity, Staging and Risk Stratification - [129]
Casselbrant ML, Mandel EM, Seroky JT et al.. “The forced-response test does not discriminate ears with different otitis media expressions.” The Laryngoscope (2014). PMID: 24550093 ↗
L4OTHERCited in: Severity, Staging and Risk Stratification, Medical versus Surgical Management (Definitive), Prognosis and Natural History - [130]
Liu K, Kaur R, Almudevar A et al.. “Higher serum levels of interleukin 10 occur at onset of acute otitis media caused by Streptococcus pneumoniae compared to Haemophilus influenzae and Moraxella catarrhalis.” The Laryngoscope (2013). PMID: 23404508 ↗
L2OTHERCited in: Severity, Staging and Risk Stratification, Prognosis and Natural History - [131]
Thanaviratananich S, Laopaiboon M, Vatanasapt P. “Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media.” The Cochrane database of systematic reviews (2013). PMID: 24338106 ↗
L1SR_OBSCited in: Severity, Staging and Risk Stratification - [132]
Thanaviratananich S, Laopaiboon M, Vatanasapt P. “Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media.” The Cochrane database of systematic reviews (2008). PMID: 18843673 ↗
L1SR_OBSCited in: Severity, Staging and Risk Stratification - [133]
Rosenfeld RM, Tunkel DE, Schwartz SR et al.. “Clinical Practice Guideline: Tympanostomy Tubes in Children (Update).” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2022). PMID: 35138954 ↗
L1GUIDELINECited in: Acute and Emergency Management, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Surgical Technique, Approaches and Perioperative Care, Special Populations and Pregnancy - [134]
Wannarong T, Ekpatanaparnich P, Boonyasiri A et al.. “Efficacy of Pneumococcal Vaccine on Otitis Media: A Systematic Review and Meta-Analysis.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2023). PMID: 36924215 ↗
L1SR_OBSCited in: Acute and Emergency Management, Surgical Technique, Approaches and Perioperative Care, Special Populations and Pregnancy - [135]
Miura MS, Mascaro M, Rosenfeld RM. “Association between otitis media and gastroesophageal reflux: a systematic review.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2011). PMID: 22157391 ↗
L2SR_OBSCited in: Acute and Emergency Management, Special Populations and Pregnancy - [136]
Gowrishankar SV, Fleet A, Tomasoni M et al.. “The Risk of Meningitis After Cochlear Implantation: A Systematic Review and Meta-Analysis.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2023). PMID: 36864717 ↗
L2SR_OBSCited in: Acute and Emergency Management, Surgical Technique, Approaches and Perioperative Care, Prevention, Screening and Surveillance - [137]
Spektor Z, Pumarola F, Ismail K et al.. “Efficacy and Safety of Ciprofloxacin Plus Fluocinolone in Otitis Media With Tympanostomy Tubes in Pediatric Patients: A Randomized Clinical Trial.” JAMA otolaryngology-- head & neck surgery (2017). PMID: 28006041 ↗
L1RCTCited in: Acute and Emergency Management, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Surgical Technique, Approaches and Perioperative Care, Prognosis and Natural History, Special Populations and Pregnancy - [138]
Hoberman A, Preciado D, Paradise JL et al.. “Tympanostomy Tubes or Medical Management for Recurrent Acute Otitis Media.” The New England journal of medicine (2021). PMID: 33979487 ↗
L1RCTCited in: Acute and Emergency Management, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Surgical Technique, Approaches and Perioperative Care, Special Populations and Pregnancy - [139]
Hoberman A, Paradise JL, Rockette HE et al.. “Shortened Antimicrobial Treatment for Acute Otitis Media in Young Children.” The New England journal of medicine (2016). PMID: 28002709 ↗
L2RCTCited in: Acute and Emergency Management, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Prognosis and Natural History, Special Populations and Pregnancy - [140]
Prymula R, Peeters P, Chrobok V et al.. “Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.” Lancet (London, England) (2006). PMID: 16517274 ↗
L1RCTCited in: Acute and Emergency Management, Medical versus Surgical Management (Definitive), History and Evolution of Treatment - [141]
Palmu AA, Jokinen J, Borys D et al.. “Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial.” Lancet (London, England) (2012). PMID: 23158882 ↗
L1RCTCited in: Acute and Emergency Management, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Special Populations and Pregnancy, Prevention, Screening and Surveillance - [142]
Bergeron M, Chang K, Ishman SL. “Cornelia de lange manifestations in otolaryngology: A systematic review and meta-analysis.” The Laryngoscope (2019). PMID: 31301187 ↗
L4SR_OBSCited in: Acute and Emergency Management - [143]
Rosso C, Bulfamante AM, Pipolo C et al.. “Adenoidectomy for middle ear disease in cleft palate children: a systematic review.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2021). PMID: 34453572 ↗
L2SR_OBSCited in: Acute and Emergency Management, Medical versus Surgical Management (Definitive), Surgical Technique, Approaches and Perioperative Care, Complications, Special Populations and Pregnancy - [144]
Schilder AG, Marom T, Bhutta MF et al.. “Panel 7: Otitis Media: Treatment and Complications.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2017). PMID: 28372534 ↗
L5REVIEW_NARRATIVECited in: Acute and Emergency Management, Surgical Technique, Approaches and Perioperative Care - [145]
Barenkamp SJ, Chonmaitree T, Hakansson AP et al.. “Panel 4: Report of the Microbiology Panel.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2017). PMID: 28372529 ↗
L5REVIEW_NARRATIVECited in: Acute and Emergency Management - [146]
Aricò MO, Trotta D, Accomando F et al.. “Pediatric acute mastoiditis: an Italian multicenter retrospective study of clinical, microbiological, and radiological features.” European journal of pediatrics (2026). PMID: 41627478 ↗
L3COHORTCited in: Acute and Emergency Management, Medical versus Surgical Management (Definitive), Surgical Technique, Approaches and Perioperative Care, Special Populations and Pregnancy - [147]
Liu YC, Dean M, Thottam PJ et al.. “Balloon Dilation of the Eustachian Tube (BDET)-A Pooled Analysis in Pediatric Patients.” The Laryngoscope (2025). PMID: 40574604 ↗
L3OTHERCited in: Acute and Emergency Management, Medical versus Surgical Management (Definitive), Surgical Technique, Approaches and Perioperative Care, Prognosis and Natural History, Special Populations and Pregnancy - [148]
Idicula WK, Jurcisek JA, Cass ND et al.. “Identification of biofilms in post-tympanostomy tube otorrhea.” The Laryngoscope (2016). PMID: 27426942 ↗
L4OTHERCited in: Acute and Emergency Management, Surgical Technique, Approaches and Perioperative Care, Complications, Special Populations and Pregnancy - [149]
Persky MJ, Roof SA, Fang Y et al.. “Cephalosporin use in penicillin-allergic patients: a survey of otolaryngologists and literature review.” The Laryngoscope (2015). PMID: 25752938 ↗
L5REVIEW_NARRATIVECited in: Acute and Emergency Management, History and Evolution of Treatment, Special Populations and Pregnancy - [150]
Banik N, Hammerstiel K, Niederle S et al.. “Homeopathic Medicines for the Treatment of Acute Otitis Media: a Real-World Cohort Study on Recurrences and Antibiotic Prescriptions Compared to those with Conventional Treatments.” Homeopathy : the journal of the Faculty of Homeopathy (2026). PMID: 41819482 ↗
L3COHORTCited in: Acute and Emergency Management - [151]
Claus J, McInnes RS, Hullegie S et al.. “The impact of topical or oral antibiotics in children with acute otitis media on their middle ear, nasopharyngeal, and gut microbiomes.” Epidemiology and infection (2026). PMID: 42333002 ↗
L1RCTCited in: Acute and Emergency Management, Medical versus Surgical Management (Definitive), History and Evolution of Treatment - [152]
Hayward G, Thompson MJ, Perera R et al.. “Corticosteroids for the common cold.” The Cochrane database of systematic reviews (2015). PMID: 26461493 ↗
L1SR_OBSCited in: Acute and Emergency Management, Medical versus Surgical Management (Definitive), Prognosis and Natural History, Special Populations and Pregnancy - [153]
Mulvaney CA, Galbraith K, Webster KE et al.. “Topical and oral steroids for otitis media with effusion (OME) in children.” The Cochrane database of systematic reviews (2023). PMID: 38088821 ↗
L1SR_OBSCited in: Acute and Emergency Management, Medical versus Surgical Management (Definitive), Complications, Special Populations and Pregnancy - [154]
Griffin G, Flynn CA. “Antihistamines and/or decongestants for otitis media with effusion (OME) in children.” The Cochrane database of systematic reviews (2011). PMID: 21901683 ↗
L1SR_OBSCited in: Acute and Emergency Management, Medical versus Surgical Management (Definitive), Special Populations and Pregnancy - [155]
Hayward G, Thompson MJ, Perera R et al.. “Corticosteroids for the common cold.” The Cochrane database of systematic reviews (2012). PMID: 22895973 ↗
L1SR_OBSCited in: Acute and Emergency Management, Medical versus Surgical Management (Definitive), Surgical Technique, Approaches and Perioperative Care, Prognosis and Natural History - [156]
Kim HO, Ha S, Lee SH et al.. “Prevalence and Global Distribution of Bacterial Species Associated with Acute Otitis Media in Children: Systematic Review and Meta-Analysis.” Antibiotics (Basel, Switzerland) (2026). PMID: 42192685 ↗
L2SR_OBSCited in: Acute and Emergency Management, Surgical Technique, Approaches and Perioperative Care, Complications - [157]
Benkendorff A, Puntscher S, Flatscher-Thöni M et al.. “Shorter versus longer antibiotic therapy for children with acute otitis media: A systematic review.” European journal of pediatrics (2026). PMID: 41764103 ↗
L1SR_OBSCited in: Acute and Emergency Management, Medical versus Surgical Management (Definitive), Complications, Prognosis and Natural History, Special Populations and Pregnancy - [158]
Kenmoe S, Dozier M, Liang J et al.. “The Burden of Respiratory Syncytial Virus in Children With Acute Otitis Media: A Systematic Review and Meta-Analysis.” Influenza and other respiratory viruses (2026). PMID: 41640273 ↗
L2SR_OBSCited in: Acute and Emergency Management, Surgical Technique, Approaches and Perioperative Care, Special Populations and Pregnancy - [159]
Hollborn H, Lachmann C, Strüder D et al.. “Rise in complications of acute otitis media during and after the COVID-19 pandemic.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2024). PMID: 38709319 ↗
L2OTHERCited in: Acute and Emergency Management, Surgical Technique, Approaches and Perioperative Care, Special Populations and Pregnancy - [160]
Kim CH, McCray LR, Nguyen SA et al.. “Use of osteopathic manipulation techniques for management of acute otitis media in pediatric patients: a scoping review.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2025). PMID: 40481343 ↗
L5REVIEW_NARRATIVECited in: Acute and Emergency Management, Medical versus Surgical Management (Definitive), Prognosis and Natural History, Special Populations and Pregnancy - [161]
Reda JD, Caye-Thomasen P. “Conservative management outcomes in acute pediatric mastoiditis.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2025). PMID: 40629169 ↗
L4OTHERCited in: Acute and Emergency Management, Medical versus Surgical Management (Definitive), Surgical Technique, Approaches and Perioperative Care, Complications, Prognosis and Natural History, Special Populations and Pregnancy - [162]
Goldberg-Bockhorn E, Hurzlmeier C, Vahl JM et al.. “Increase in acute mastoiditis at the end of the COVID-19 pandemic.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2024). PMID: 38740579 ↗
L4OTHERCited in: Acute and Emergency Management, Surgical Technique, Approaches and Perioperative Care, Complications, Special Populations and Pregnancy - [163]
Gawęcki W, Karlik M, Borucki Ł et al.. “Skin flap complications after cochlear implantations.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2016). PMID: 27245752 ↗
L4OTHERCited in: Acute and Emergency Management, Medical versus Surgical Management (Definitive), Surgical Technique, Approaches and Perioperative Care, Complications - [164]
Rubin LG. “Prevention and treatment of meningitis and acute otitis media in children with cochlear implants.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2010). PMID: 20802367 ↗
L5REVIEW_NARRATIVECited in: Acute and Emergency Management, Surgical Technique, Approaches and Perioperative Care, Special Populations and Pregnancy - [165]
Creighton FX, Kozin E, Rong A et al.. “Outcomes Following Transcanal Endoscopic Lateral Graft Tympanoplasty.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2019). PMID: 31568133 ↗
L4OTHERCited in: Acute and Emergency Management, Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Surgical Technique, Approaches and Perioperative Care, Prognosis and Natural History, Special Populations and Pregnancy - [166]
Rosenfeld RM, Tunkel DE, Schwartz SR et al.. “Executive Summary of Clinical Practice Guideline on Tympanostomy Tubes in Children (Update).” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2022). PMID: 35138976 ↗
L1GUIDELINECited in: Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Special Populations and Pregnancy - [167]
Andreoli SM, Schlosser RJ, Wang LF et al.. “Adenoid ciliostimulation in children with chronic otitis media.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2012). PMID: 23032917 ↗
L2RCTCited in: Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Prognosis and Natural History - [168]
Goel AN, Omorogbe A, Hackett A et al.. “Risk Factors for Multiple Tympanostomy Tube Placements in Children: Systematic Review and Meta-Analysis.” The Laryngoscope (2020). PMID: 33382113 ↗
L2SR_OBSCited in: Medical versus Surgical Management (Definitive), Surgical Technique, Approaches and Perioperative Care, Prognosis and Natural History, Special Populations and Pregnancy - [169]
Hong P, Smith N, Johnson LB et al.. “A randomized double-blind controlled trial of phosphorylcholine-coated tympanostomy tube versus standard tympanostomy tube in children with recurrent acute and chronic otitis media.” The Laryngoscope (2011). PMID: 21072756 ↗
L1RCTCited in: Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Surgical Technique, Approaches and Perioperative Care - [170]
Kinnari TJ, Rihkanen H, Laine T et al.. “Role of albumin coating of tympanostomy tubes: long-term clinical evaluation.” The Laryngoscope (2007). PMID: 17921900 ↗
L1RCTCited in: Medical versus Surgical Management (Definitive), Complications, Prognosis and Natural History - [171]
Torretta S, Marchisio P, Rinaldi V et al.. “Endoscopic and clinical benefits of hyaluronic acid in children with chronic adenoiditis and middle ear disease.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2016). PMID: 27695944 ↗
L1RCTCited in: Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Surgical Technique, Approaches and Perioperative Care - [172]
Marchisio P, Chonmaitree T, Leibovitz E et al.. “Panel 7: Treatment and comparative effectiveness research.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2013). PMID: 23536528 ↗
L5REVIEW_NARRATIVECited in: Medical versus Surgical Management (Definitive), Surgical Technique, Approaches and Perioperative Care, Prognosis and Natural History - [173]
Clark A, Forner D, Noel CW et al.. “Need for Tympanostomy Tubes in Children With Recurrent Acute Otitis Media Without Middle Ear Effusion.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2023). PMID: 36939487 ↗
L4OTHERCited in: Medical versus Surgical Management (Definitive) - [174]
Raol N, Sharma M, Boss EF et al.. “Tympanostomy Tube Placement vs Medical Management for Recurrent Acute Otitis Media in TRICARE-Insured Children.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2017). PMID: 28535362 ↗
L2OTHERCited in: Medical versus Surgical Management (Definitive) - [175]
Kozyrskyj A, Klassen TP, Moffatt M et al.. “Short-course antibiotics for acute otitis media.” The Cochrane database of systematic reviews (2010). PMID: 20824827 ↗
L1SR_OBSCited in: Medical versus Surgical Management (Definitive), Prognosis and Natural History - [176]
Coleman C, Moore M. “WITHDRAWN: Decongestants and antihistamines for acute otitis media in children.” The Cochrane database of systematic reviews (2011). PMID: 21412874 ↗
L1SR_OBSCited in: Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Surgical Technique, Approaches and Perioperative Care, Complications - [177]
Coleman C, Moore M. “Decongestants and antihistamines for acute otitis media in children.” The Cochrane database of systematic reviews (2008). PMID: 18646076 ↗
L1SR_OBSCited in: Medical versus Surgical Management (Definitive) - [178]
MacKeith S, Mulvaney CA, Galbraith K et al.. “Ventilation tubes (grommets) for otitis media with effusion (OME) in children.” The Cochrane database of systematic reviews (2023). PMID: 37965944 ↗
L1SR_OBSCited in: Medical versus Surgical Management (Definitive) - [179]
Griffin GH, Flynn C, Bailey RE et al.. “Antihistamines and/or decongestants for otitis media with effusion (OME) in children.” The Cochrane database of systematic reviews (2006). PMID: 17054169 ↗
L1SR_OBSCited in: Medical versus Surgical Management (Definitive) - [180]
Azarpazhooh A, Lawrence HP, Shah PS. “Xylitol for preventing acute otitis media in children up to 12 years of age.” The Cochrane database of systematic reviews (2016). PMID: 27486835 ↗
L1SR_OBSCited in: Medical versus Surgical Management (Definitive) - [181]
Lau L, Mick P, Nunez DA. “WITHDRAWN: Grommets (ventilation tubes) for recurrent acute otitis media in children.” The Cochrane database of systematic reviews (2018). PMID: 29624209 ↗
L1SR_OBSCited in: Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Prognosis and Natural History - [182]
Venekamp RP, Burton MJ, van Dongen TM et al.. “Antibiotics for otitis media with effusion in children.” The Cochrane database of systematic reviews (2016). PMID: 27290722 ↗
L1SR_OBSCited in: Medical versus Surgical Management (Definitive), Complications, Prognosis and Natural History - [183]
Flynn CA, Griffin GH, Schultz JK. “WITHDRAWN: Decongestants and antihistamines for acute otitis media in children.” The Cochrane database of systematic reviews (2007). PMID: 17636682 ↗
L1SR_OBSCited in: Medical versus Surgical Management (Definitive), History and Evolution of Treatment - [184]
Albazah NIJ, Loh HM, Lee JY et al.. “Critical appraisal of clinical practice guidelines for otitis media in Asian and Western countries with consideration of updates: A narrative review.” Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia (2024). PMID: 39654866 ↗
L5GUIDELINECited in: Medical versus Surgical Management (Definitive) - [185]
Anderson JL, Oliveira J E Silva L, Hess EP et al.. “Shared decision-making for pediatric acute otitis media in the United States: a randomized emergency department trial.” BMC emergency medicine (2025). PMID: 40753428 ↗
L1RCTCited in: Medical versus Surgical Management (Definitive), History and Evolution of Treatment - [186]
Hullegie S, Damoiseaux RAMJ, Hay AD et al.. “Topical or oral antibiotics in childhood acute otitis media and ear discharge: a randomized controlled non-inferiority trial.” Family practice (2024). PMID: 38912621 ↗
L1RCTCited in: Medical versus Surgical Management (Definitive), History and Evolution of Treatment, Prognosis and Natural History - [187]
Kaffenberger TM, Belsky MA, Oberlies NR et al.. “Long-term Impact of Middle Ear Effusion in Pediatric Tympanostomy Tubes.” The Laryngoscope (2020). PMID: 32621539 ↗
L4OTHERCited in: Medical versus Surgical Management (Definitive), Surgical Technique, Approaches and Perioperative Care, Complications, Prognosis and Natural History - [188]
Habib AR, Crossland G, Sacks R et al.. “Tele-otology for Aboriginal and Torres Strait Islander People Living in Rural and Remote Areas.” The Laryngoscope (2024). PMID: 38982868 ↗
L2OTHERCited in: Medical versus Surgical Management (Definitive) - [189]
Billings KR, Hajduk J, Thompson DM. “Single Visit Evaluation and Tympanostomy Tube Placement for the Treatment of Acute Otitis Media in Children.” The Laryngoscope (2021). PMID: 34213781 ↗
L2OTHERCited in: Medical versus Surgical Management (Definitive) - [190]
Ho AC, Chan JY, Ng RW et al.. “Stenting of the eustachian tube to prevent otitis media with effusion after maxillary swing approach nasopharyngectomy.” The Laryngoscope (2013). PMID: 23878003 ↗
L2OTHERCited in: Medical versus Surgical Management (Definitive), Complications - [191]
Davies T, Peng X, Salem J et al.. “A Systematic Review and Meta-Analysis of the Efficacy of Antimicrobial Chemoprophylaxis for Recurrent Acute Otitis Media in Children.” Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery (2024). PMID: 39394875 ↗
L1SR_OBSCited in: Medical versus Surgical Management (Definitive), Complications - [192]
Varanasi R, Bhalerao R, Sumithran P et al.. “A Comparative Randomized Controlled Trial of Homeopathy versus Allopathy in Acute Otitis Media and Its Recurrence in Children.” Complementary medicine research (2025). PMID: 39864417 ↗
L1RCTCited in: Medical versus Surgical Management (Definitive) - [193]
Rubini A, Ronzani G, D'Alessandro E et al.. “Management of Otogenic Meningitis: A Proposal for Practical Guidelines from a Multicenter Experience with a Systematic Review.” Journal of clinical medicine (2024). PMID: 39336995 ↗
L4SR_OBSCited in: Medical versus Surgical Management (Definitive) - [194]
Baljosevic I, Mircetic N, Subarevic V et al.. “Acute mastoiditis in infants.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2006). PMID: 16794812 ↗
L4OTHERCited in: Medical versus Surgical Management (Definitive) - [195]
George M, Alexander A, Mathew J et al.. “Proposal of a timing strategy for cholesteatoma surgery during the COVID-19 pandemic.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2020). PMID: 32415348 ↗
L5OTHERCited in: Medical versus Surgical Management (Definitive), Complications - [196]
Gorphe P, de Barros A, Choussy O et al.. “Acute mastoiditis in children: 10 years experience in a French tertiary university referral center.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2011). PMID: 21713452 ↗
L4OTHERCited in: Medical versus Surgical Management (Definitive), Complications - [197]
Torretta S, Marchisio P, Rinaldi V et al.. “In reply to "Commentary to: Endoscopic and clinical benefits of hyaluronic acid in children with chronic adenoiditis and middle ear disease", by Zhengcai Lou.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2018). PMID: 29423745 ↗
L5OTHERCited in: Medical versus Surgical Management (Definitive) - [198]
Wang X, Fernandez R, Tsivkovskaia N et al.. “OTO-201: nonclinical assessment of a sustained-release ciprofloxacin hydrogel for the treatment of otitis media.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2014). PMID: 24518407 ↗
L5OTHERCited in: Medical versus Surgical Management (Definitive), Complications - [199]
Pawlowski K, Koulich E, Wright CG et al.. “Ototopic applications of povidone iodine/dexamethasone in the rat.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2013). PMID: 23202157 ↗
L5OTHERCited in: Medical versus Surgical Management (Definitive) - [200]
Antonelli PJ, Winterstein AG, Schultz GS. “Topical dexamethasone and tympanic membrane perforation healing in otitis media: a short-term study.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2010). PMID: 20010446 ↗
L5OTHERCited in: Medical versus Surgical Management (Definitive), Prognosis and Natural History - [201]
Fiedler T, Boeger D, Buentzel J et al.. “Middle ear surgery in Thuringia, Germany: a population-based regional study on epidemiology and outcome.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2013). PMID: 23370571 ↗
L4OTHERCited in: Medical versus Surgical Management (Definitive), Prognosis and Natural History - [202]
Anon JB, Jacobs MR, Poole MD et al.. “Antimicrobial treatment guidelines for acute bacterial rhinosinusitis.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2004). PMID: 14726904 ↗
L1GUIDELINECited in: History and Evolution of Treatment - [203]
Rosenfeld RM, Culpepper L, Doyle KJ et al.. “Clinical practice guideline: Otitis media with effusion.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2004). PMID: 15138413 ↗
L1GUIDELINECited in: History and Evolution of Treatment - [204]
Hsu GS, Levine SC, Giebink GS. “Management of otitis media using Agency for Health Care Policy and Research guidelines. The Agency for Health Care Policy and Research.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (1998). PMID: 9560092 ↗
L4GUIDELINECited in: History and Evolution of Treatment - [205]
Rosenfeld RM, Kay D. “Natural history of untreated otitis media.” The Laryngoscope (2003). PMID: 14520089 ↗
L1SR_OBSCited in: History and Evolution of Treatment - [206]
Puczynski MS, Stankiewicz JA, O'Keefe JP. “Single dose amoxicillin treatment of acute otitis media.” The Laryngoscope (1987). PMID: 3796171 ↗
L1RCTCited in: History and Evolution of Treatment - [207]
Gonzalez C, Arnold JE, Woody EA et al.. “Prevention of recurrent acute otitis media: chemoprophylaxis versus tympanostomy tubes.” The Laryngoscope (1986). PMID: 3537596 ↗
L1RCTCited in: History and Evolution of Treatment - [208]
Roland PS, Anon JB, Moe RD et al.. “Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes.” The Laryngoscope (2003). PMID: 14660913 ↗
L1RCTCited in: History and Evolution of Treatment - [209]
Eskola J, Kilpi T, Palmu A et al.. “Efficacy of a pneumococcal conjugate vaccine against acute otitis media.” The New England journal of medicine (2001). PMID: 11172176 ↗
L1RCTCited in: History and Evolution of Treatment - [210]
Shurin PA, Pelton SI, Donner A et al.. “Persistence of middle-ear effusion after acute otitis media in children.” The New England journal of medicine (1979). PMID: 431635 ↗
L2RCTCited in: History and Evolution of Treatment - [211]
Hughes WT, Kuhn S, Chaudhary S et al.. “Successful chemoprophylaxis for Pneumocystis carinii pneumonitis.” The New England journal of medicine (1977). PMID: 412099 ↗
L1RCTCited in: History and Evolution of Treatment - [212]
van Buchem FL, Dunk JH, van't Hof MA. “Therapy of acute otitis media: myringotomy, antibiotics, or neither? A double-blind study in children.” Lancet (London, England) (1981). PMID: 6117681 ↗
L1RCTCited in: History and Evolution of Treatment - [213]
Ukkonen P, Varis K, Jernfors M et al.. “Treatment of acute otitis media with an antiadhesive oligosaccharide: a randomised, double-blind, placebo-controlled trial.” Lancet (London, England) (2000). PMID: 11052582 ↗
L1RCTCited in: History and Evolution of Treatment - [214]
Veenhoven R, Bogaert D, Uiterwaal C et al.. “Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study.” Lancet (London, England) (2003). PMID: 12842372 ↗
L1RCTCited in: History and Evolution of Treatment - [215]
Engelhard D, Cohen D, Strauss N et al.. “Randomised study of myringotomy, amoxycillin/clavulanate, or both for acute otitis media in infants.” Lancet (London, England) (1989). PMID: 2567903 ↗
L1RCTCited in: History and Evolution of Treatment - [216]
Ragab SM. “The effect of radiofrequency and mitomycin C on the closure rate of human tympanostomy.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2005). PMID: 15891633 ↗
L1RCTCited in: History and Evolution of Treatment - [217]
Albersen M, Bulatović M, Lindner SH et al.. “Is a positive family history predictive for recurrent acute otitis media in children? An evidence-based case report.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2010). PMID: 20096220 ↗
L5CASE_REPORTCited in: History and Evolution of Treatment - [218]
Rosenfeld RM, Casselbrant ML, Hannley MT. “Implications of the AHRQ evidence report on acute otitis media.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2001). PMID: 11700439 ↗
L5OTHERCited in: History and Evolution of Treatment - [219]
Acuin J, Smith A, Mackenzie I. “WITHDRAWN: Interventions for chronic suppurative otitis media.” The Cochrane database of systematic reviews (2007). PMID: 17636638 ↗
L1SR_OBSCited in: History and Evolution of Treatment - [220]
Norhayati MN, Ho JJ, Azman MY. “Influenza vaccines for preventing acute otitis media in infants and children.” The Cochrane database of systematic reviews (2015). PMID: 25803008 ↗
L1SR_OBSCited in: History and Evolution of Treatment - [221]
Norhayati MN, Ho JJ, Azman MY. “Influenza vaccines for preventing acute otitis media in infants and children.” The Cochrane database of systematic reviews (2017). PMID: 29039160 ↗
L1SR_OBSCited in: History and Evolution of Treatment - [222]
Fortanier AC, Venekamp RP, Boonacker CW et al.. “Pneumococcal conjugate vaccines for preventing acute otitis media in children.” The Cochrane database of systematic reviews (2019). PMID: 31135969 ↗
L1SR_OBSCited in: History and Evolution of Treatment, Prevention, Screening and Surveillance - [223]
de Sévaux JL, Venekamp RP, Lutje V et al.. “Pneumococcal conjugate vaccines for preventing acute otitis media in children.” The Cochrane database of systematic reviews (2020). PMID: 33231293 ↗
L1SR_OBSCited in: History and Evolution of Treatment, Prevention, Screening and Surveillance - [224]
Jansen AG, Hak E, Veenhoven RH et al.. “Pneumococcal conjugate vaccines for preventing otitis media.” The Cochrane database of systematic reviews (2009). PMID: 19370566 ↗
L1SR_OBSCited in: History and Evolution of Treatment, Prevention, Screening and Surveillance - [225]
Fortanier AC, Venekamp RP, Boonacker CW et al.. “Pneumococcal conjugate vaccines for preventing otitis media.” The Cochrane database of systematic reviews (2014). PMID: 24696098 ↗
L1SR_OBSCited in: History and Evolution of Treatment, Prevention, Screening and Surveillance - [226]
Teichgraeber JF, Per-Lee JH, Turner JS. “Lateral sinus thrombosis: a modern perspective.” The Laryngoscope (1982). PMID: 7087642 ↗
L4CASE_REPORTCited in: History and Evolution of Treatment - [227]
Moloy PJ. “Anaerobic mastoiditis: a report of two cases with complications.” The Laryngoscope (1982). PMID: 7144403 ↗
L4CASE_REPORTCited in: History and Evolution of Treatment - [228]
Reath JS, O'Brien S, Campbell L et al.. “The views of parents and carers on managing acute otitis media in urban Aboriginal and Torres Strait Islander children: a qualitative study.” The Medical journal of Australia (2024). PMID: 38266503 ↗
L5RCTCited in: History and Evolution of Treatment, Prognosis and Natural History - [229]
Sarlin S, Koskela U, Honkila M et al.. “Streptococcus salivarius Probiotics to Prevent Acute Otitis Media in Children: A Randomized Clinical Trial.” JAMA network open (2023). PMID: 37917062 ↗
L1RCTCited in: History and Evolution of Treatment, Prevention, Screening and Surveillance - [230]
Persaud N, Azarpazhooh A, Keown-Stoneman C et al.. “Xylitol for the prevention of acute otitis media episodes in children aged 1-5 years: a randomised controlled trial.” Archives of disease in childhood (2024). PMID: 37890960 ↗
L1RCTCited in: History and Evolution of Treatment - [231]
Folino F, Di Pasquale D, Marchisio P et al.. “Topical administration of S. salivarius 24SMB-S. oralis 89a in children with adenoidal disease: a double-blind controlled trial.” European journal of pediatrics (2023). PMID: 37874401 ↗
L2RCTCited in: History and Evolution of Treatment - [232]
Huyett P, Sturm JJ, Shaffer AD et al.. “Second tympanostomy tube placement in children with recurrent acute otitis media.” The Laryngoscope (2017). PMID: 28990661 ↗
L2OTHERCited in: History and Evolution of Treatment, Surgical Technique, Approaches and Perioperative Care, Special Populations and Pregnancy - [233]
Luntz M, Hodges AV, Balkany T et al.. “Otitis media in children with cochlear implants.” The Laryngoscope (1996). PMID: 8914909 ↗
L4OTHERCited in: History and Evolution of Treatment - [234]
Redaelli de Zinis LO, Gamba P, Balzanelli C. “Acute otitis media and facial nerve paralysis in adults.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2003). PMID: 12544039 ↗
L4CASE_REPORTCited in: History and Evolution of Treatment - [235]
Ribaut B, Ayari-Khalfallah S, Truy E et al.. “Epidemiological evolution of acute mastoiditis in children after COVID-19 pandemic.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2025). PMID: 40699229 ↗
L2OTHERCited in: History and Evolution of Treatment - [236]
Caylan R, Bektas D, Atalay C et al.. “Prevalence and risk factors of otitis media with effusion in Trabzon, a city in northeastern Turkey, with an emphasis on the recommendation of OME screening.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2005). PMID: 16328401 ↗
L2OTHERCited in: History and Evolution of Treatment, Prevention, Screening and Surveillance - [237]
Tawfik KO, Ishman SL, Altaye M et al.. “Pediatric Acute Otitis Media in the Era of Pneumococcal Vaccination.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2017). PMID: 28349737 ↗
L2OTHERCited in: Surgical Technique, Approaches and Perioperative Care, Prognosis and Natural History, Prevention, Screening and Surveillance - [238]
Spinks A, Glasziou PP, Del Mar CB. “Antibiotics for sore throat.” The Cochrane database of systematic reviews (2013). PMID: 24190439 ↗
L1SR_OBSCited in: Surgical Technique, Approaches and Perioperative Care - [239]
Darlison P, Moresco L, Nussbaumer-Streit B et al.. “Decongestants and antihistamines for acute otitis media in children.” The Cochrane database of systematic reviews (2025). PMID: 41307300 ↗
L1SR_OBSCited in: Surgical Technique, Approaches and Perioperative Care - [240]
Sarno M, Pascarella A, De Lucia A et al.. “Epidemiological and Clinical Changes in Pediatric Acute Mastoiditis Before and After the COVID-19 Pandemic: An Eight-Year Retrospective Study from a Tertiary-Level Center.” Medical sciences (Basel, Switzerland) (2025). PMID: 41440529 ↗
L2COHORTCited in: Surgical Technique, Approaches and Perioperative Care, Prognosis and Natural History, Prevention, Screening and Surveillance - [241]
Stefani M, Beccaria K, Galland A et al.. “Ear and nose-related intracranial empyema in children: a 9-year cohort study from a tertiary referral center.” Neurosurgical focus (2025). PMID: 41175410 ↗
L2COHORTCited in: Surgical Technique, Approaches and Perioperative Care, Complications - [242]
Chinnadurai S, Meyer C, Roby B et al.. “Reduction of Antibiotic-Associated Conditions After Tympanostomy Tube Placement in Children.” The Laryngoscope (2024). PMID: 39172004 ↗
L2OTHERCited in: Surgical Technique, Approaches and Perioperative Care - [243]
Walker NR, Eleftheriadou A, Mortaja S et al.. “Surgical interventions in acute complicated mastoiditis - is a cortical mastoidectomy always required? A 5-year retrospective cohort study.” The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland (2025). PMID: 39956720 ↗
L2COHORTCited in: Surgical Technique, Approaches and Perioperative Care, Complications - [244]
Han L, Gao C, Liu J et al.. “Pneumococcal vaccine for prevention of acute otitis media in children: a meta-analysis.” BMC infectious diseases (2026). PMID: 41606517 ↗
L1SR_OBSCited in: Surgical Technique, Approaches and Perioperative Care - [245]
Calvo-Henriquez C, Solano Marmolejo M, Saura Vilela I et al.. “Assessing the role of adenoid biofilm on children in different ENT diseases. A state-of-the-art systematic review.” Acta otorrinolaringologica espanola (2025). PMID: 41344444 ↗
L2SR_OBSCited in: Surgical Technique, Approaches and Perioperative Care - [246]
Venekamp RP, Mick P, Schilder AG et al.. “Grommets (ventilation tubes) for recurrent acute otitis media in children.” The Cochrane database of systematic reviews (2018). PMID: 29741289 ↗
L1SR_OBSCited in: Complications, Prognosis and Natural History, Prevention, Screening and Surveillance - [247]
Ranakusuma RW, Pitoyo Y, Safitri ED et al.. “Systemic corticosteroids for acute otitis media in children.” The Cochrane database of systematic reviews (2018). PMID: 29543327 ↗
L1SR_OBSCited in: Complications - [248]
Gisselsson-Solen M, Gunasekera H, Hall A et al.. “Panel 1: Epidemiology and global health, including child development, sequelae and complications.” International journal of pediatric otorhinolaryngology (2024). PMID: 38340606 ↗
L2SR_OBSCited in: Complications - [249]
Corona K, Saripada JAI, Wermine K et al.. “Risk of COVID-19 in pediatric population and the effects of COVID-19 vaccination: A retrospective cohort study.” Auris, nasus, larynx (2024). PMID: 38520981 ↗
L2COHORTCited in: Complications, Prevention, Screening and Surveillance - [250]
Stenfeldt K, Hermansson A. “Acute mastoiditis in southern Sweden: a study of occurrence and clinical course of acute mastoiditis before and after introduction of new treatment recommendations for AOM.” European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2010). PMID: 20614127 ↗
L2OTHERCited in: Complications - [251]
Kisser U, Gürkov R, Louza J et al.. “Comparison of characteristics of titanium and fluoroplastic ventilation tubes in adults with healthy middle ears.” Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (2012). PMID: 22772000 ↗
L4OTHERCited in: Complications - [252]
Kim MS, Kim JH, Ryu S et al.. “Comparative efficacy and optimal duration of first-line antibiotic regimens for acute otitis media in children and adolescents: a systematic review and network meta-analysis of 89 randomized clinical trials.” World journal of pediatrics : WJP (2023). PMID: 37016201 ↗
L1SR_OBSCited in: Prognosis and Natural History - [253]
Shaikh N, Hoberman A, Paradise JL et al.. “Association Between Nasopharyngeal Colonization and Clinical Outcome in Children With Acute Otitis Media.” The Pediatric infectious disease journal (2023). PMID: 37171965 ↗
L1RCTCited in: Prognosis and Natural History - [254]
Osgood R, Salamone F, Diaz A et al.. “Effect of pH and oxygen on biofilm formation in acute otitis media associated NTHi clinical isolates.” The Laryngoscope (2015). PMID: 25970856 ↗
L5OTHERCited in: Prognosis and Natural History - [255]
Iqbal IS, Puyo EM, Carnino JM et al.. “Pediatric Acute Otitis Media Clinical Trials: An Analysis of Diversity.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2024). PMID: 39737659 ↗
L5TRIAL_NONRANDOMCited in: Special Populations and Pregnancy - [256]
Lambert-Hoffert A, Tarazona V, Ben Romdhane T et al.. “Clinical Practice Guidelines for Managing Acute Otitis Media: Literature Review and Systematic Mapping of the Evidence Base.” Journal of evaluation in clinical practice (2025). PMID: 40717508 ↗
L5GUIDELINECited in: Special Populations and Pregnancy - [257]
Holland C, Oakes D, Sarna MM et al.. “Systematic review and meta-analysis of the non-specific and broader impact of respiratory vaccines on acute lower respiratory infections in young children.” BMJ open (2025). PMID: 41344710 ↗
L1SR_OBSCited in: Special Populations and Pregnancy, Prevention, Screening and Surveillance - [258]
Fischer JL, Riley CA, Hsieh MC et al.. “Prevalence of Eustachian Tube Dysfunction in the US Elderly Population.” Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2020). PMID: 32573346 ↗
L4OTHERCited in: Prevention, Screening and Surveillance - [259]
Izurieta P, AbdelGhany M, Borys D. “Serotype distribution of invasive and non-invasive pneumococcal disease in children ≤5 years of age following the introduction of 10- and 13-valent pneumococcal conjugate vaccines in infant national immunization programs: a systematic literature review.” Frontiers in public health (2025). PMID: 40520299 ↗
L2SR_OBSCited in: Prevention, Screening and Surveillance - [260]
Sapir A, Lasry B, Hazan I et al.. “Acute otitis media in the first two months of life and the impact of pneumococcal conjugate vaccines: A retrospective cohort study.” International journal of pediatric otorhinolaryngology (2023). PMID: 37060826 ↗
L2COHORTCited in: Prevention, Screening and Surveillance